https://www.endosure.info/womenhealthlinksclinicca daily 1.0 2026-05-23 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/47af15ff-fee3-4a78-8835-7b97b05c6ca7/logo.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/72460e21-3183-4476-9492-4e8a29963957/qrCode+%281%29.png https://www.endosure.info/about daily 0.75 2026-03-31 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6fc8594a-202a-4fcc-ad00-6fa6fe407f4d/qrCode+%281%29.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1774736608352-Q50I7143AEOHMGGIWL9G/unsplash-image-l9gmNv3q7Z4.jpg https://www.endosure.info/contact daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c8b691a3-1f8b-4211-8c61-9e84b563dfb4/qrCode+%281%29.png https://www.endosure.info/about-2 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b4e60838-61a3-4064-a729-7d8580eab10e/EGG+for+endometriosis.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/050861ee-a4fe-44f9-bc94-cd812ed3d67e/NIH+26fd34ba-2c35-4afe-804b-961d6ef8d912.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b1014298-687f-4c6a-9fb1-4340d7a437b3/early+diagnosis.png https://www.endosure.info/about-3 daily 0.75 2026-04-15 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0bc09f94-3cd1-4455-be66-86a037e7d77d/lipiodol+1.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/87d39ff8-f079-4b32-986a-8c3f3af1ed2b/lipiodol+8.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0ed65ae2-c6c4-4007-a07a-aba483df24e6/dr-Azer-protocol-for-infertility-and-endometriosis-Apr-13%2C-12-25-PM-image-2+%281%29.jpg https://www.endosure.info/about-4 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/01be7b29-1f45-4cc4-bb33-5b180fa2b546/81ac2b0e-0347-4751-a7fa-220c4ec88733.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4820b8a9-5fc9-4454-9690-e35f825ed1dc/Gemini_Generated_Image_gtdvwgtdvwgtdvwg.png https://www.endosure.info/about-5 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cb615cd9-3ca4-4ed0-8ce4-adea0d1d685f/AMH.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9a8de85b-f4a4-42e3-ae5f-179e7af7e04c/metformin+and+pcos1.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4cc22911-afa1-4bf9-b626-3e7bce047a9f/pcos+2.png https://www.endosure.info/about-80 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/95baa2b5-de2c-4344-a43a-0b1a438bb84f/treatment+options.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a4a56a42-4f24-4990-91bd-c201aa16b938/multidimentional+menopause.png https://www.endosure.info/about-90 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d138a6e4-dc51-409c-bdff-682710f76080/perimenopause+and+body+alteration.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/682fd85c-5627-4007-bf9a-f5386e3c2203/perimenopause+integrative+approch.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/79397398-e2db-462d-b508-766a447511be/perimenopause+and+cvd.jpg https://www.endosure.info/about-23 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a51fef5-98e7-4686-b611-12c3793c12b4/pcos+phenotype.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b0aa854f-e1ee-4b4c-9407-a52cdf4f901b/Untitled-2.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3494990f-bd9e-4b22-adb5-3809b2f3d391/pcos+treatment.png https://www.endosure.info/new-page daily 0.75 2026-05-18 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/79e26f3b-fd94-45b3-98b1-f42af08b8f7f/qrCode+%282%29.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/347c8c4f-4af1-4072-95b9-3da87b697344/qrCode+%283%29.png https://www.endosure.info/gallery-1 daily 0.75 2026-05-07 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4d5e93dd-6182-40e9-9a71-1ec04509054c/Adenomyosis-is-the-presence-of-endometrial-glands-and-stroma-within-the%E2%80%A6-image-1.jpg Gallery Infographic showing the impact of adenomyosis on fertility, including uterine anatomy, symptoms, diagnosis, treatment, and pregnancy management. Features an illustration of the uterus, symptoms like abnormal bleeding and pelvic pain, diagnosis methods, treatment options, and reproductive impact statistics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fbc3a4e4-a26f-496a-a954-c42fc1293301/Lipiodol-%28oil-based-contrast-medium%29-used-during-hysterosalpingography%E2%80%A6-image-1.jpg Gallery Diagram illustrating lipiodol HSG in women with endometriosis and patent tubes. Sections include concept overview, clinical evidence (with bar graphs showing pregnancy and live birth rates over 6 months), mechanisms (tubal flushing, endometrial receptivity), clinical application (attempt natural conception in 6 months), and a take-home message emphasizing safety, simplicity, and transient benefits of lipiodol HSG for endometriosis-related infertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f1a6ee32-e231-4f4c-81b7-47cf77b03027/Most-SVTs-occur-in-patients-with-varicose-veins%2C15-yet-evidence-based-g%E2%80%A6-image-1.jpg Gallery Diagram of a clinical study on early endovenous thermal ablation (EVTA) for treating superficial venous disease (SVT). It shows patient selection, intervention with EVTA, and key outcomes in efficacy and safety, including pain reduction, VCSS, VEINES-QOL improvements, and safety data like DVT rate, recurrence, and bleeding. The timeline indicates a median follow-up of 14 months. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1bb4861f-6be3-4ad1-bf19-85af04227d34/Proposed-Optimal-Sequencing-Strategy-Based-on-the-mechanistic-rationale%E2%80%A6-image-1.jpg Gallery Diagram illustrating a proposed sequencing strategy for women with endometriosis-related infertility and patent tubes, including cycles of ovarian stimulation, IUI, ovulation, and IVF procedures, with a combination pathway diagram at the bottom. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4420e259-e1f6-41cd-8fb4-be10ce3fba8f/Summary-For-women-with-endometriosis-related-infertility-and-patent-tu%E2%80%A6-image-1.jpg Gallery Flowchart displaying the optimized treatment strategy for endometriosis-related infertility using patent tubes. It starts with a woman diagnosed with endometriosis-related infertility, proceeding to a patent fallopian tube test. The first-line intervention is oil-based tubal patency test using Lipiodol HSG. Up to six months later, if no pregnancy occurs, there are options: attempt spontaneous conception, ovary stimulation or intrauterine insemination (IUI), or proceed with in-vitro fertilization (IVF). Lipiodol HSG can lower treatment burden and cost, or IVF can be considered based on age and clinical factors. If pregnancy is confirmed within six months, no further action is needed. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7d43f20c-3ab0-4a49-b3d6-dd290e65580b/The-6-month-pregnancy-rate-of-48%25-with-lipiodol-in-the-FLUSH-trial-endo%E2%80%A6-image-1.jpg Gallery Flowchart illustrating treatment pathway for Lipiodol HSG, ovarian stimulation/IUI, and IVF, with comparative outcomes, costs, and key advantages of Lipiodol HSG infographics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/90d55d75-16ce-4337-93ec-cea1d19fc833/Endometriosis-is-a-chronic-gynecological-disorder-that-affects-approxim%E2%80%A6-image-1.jpg Gallery Infographic titled 'Current Diagnostic and Therapeutic Strategies in Adolescent Endometriosis'. It illustrates aspects of adolescent endometriosis including prevalence, diagnostic pathways, clinical challenges, emerging innovations, and treatment strategies. Features include a diagram of the female reproductive system, icons for ultrasound, MRI, laparoscopy, and various medical devices, along with explanatory text and icons for pain, symptoms, diagnosis, and therapy goals. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c8f411c-ae17-4f12-9778-97c98c7a53bd/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1+%281%29.jpg Gallery Comparison chart of fertility window detection methods in women with idiopathic infertility, including ovul Device, urine test strips, and folliculometry, showing diagnostic performance, comparison Venn diagram, process diagrams, and key findings. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dc6cf007-cf84-4e5b-88f5-9cf5f33798d8/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1.jpg Gallery A comparison chart displaying different methods for detecting ovulatory fertility in women with idiopathic infertility. It includes visual flowcharts, Venn diagrams, and summary tables. Sections illustrate the process flow from ovulation induction and natural cycle analysis to the use of ovulography, urine tests, and folliculometry, highlighting their diagnostic accuracy, sensitivity, and specificity. The chart emphasizes the high accuracy and home use benefits of ovulography compared to other methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cae4e3d2-5357-4dae-8066-91abf9fe1a56/The-impact-of-endometrioma-size-on-ovarian-reserve-remains-controversia%E2%80%A6-image-1.jpg Gallery Flowchart comparing cyst size and hormone levels in women with endometriomas and controls, highlighting increased AMH with larger cysts, and advising interpretation in context of endometrioma for ovarian reserve. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c63fd8b-7bdc-460c-a51a-cb55bb0e537d/The-perception-that-hormonal-contraception-causes-weight-gain-is-a-gene%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Impact of Hormonal Contraceptives on Weight Gain' that explains mechanisms, evidence, and perceptions surrounding hormonal contraceptives and weight gain. The infographic includes sections on patient perception versus scientific evidence, methods of contraception comparison, mechanisms of fluid retention and DMPA-induced fat gain, and misconceptions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/30f5f74d-f526-4dc1-a3ac-25487397d6ed/Endometriosis-is-a-chronic-gynecological-disorder-that-affects-approxim%E2%80%A6-image-1.jpg Gallery Infographic on adolescent endometriosis diagnosis and treatment. Sections include overview, diagnostic pathway, clinical challenges, emerging innovations, and therapeutic strategies. Visuals depict uterus, symptoms, diagnostics, treatment options, and improved quality of life. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/16ae6431-ea99-4f92-9e3a-8d5c0c89ee14/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1+%281%29.jpg Gallery A scientific infographic comparing fertility window detection methods in women with idiopathic infertility, including ovulography devices, urine test strips, and folliculometry. It shows test procedures, diagnostic performance metrics, overlap of positive results, and key home use advantages. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f5b52d9d-8750-4d0a-a49e-fd605e70502d/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1.jpg Gallery Diagram comparing fertility window detection methods in women with idiopathic infertility, including ovulometry, urine test strips, and folliculometry, with charts illustrating test overlap, performance metrics, and key benefits for home use. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4db346c1-d02e-4fae-84d2-34e41c943563/The-impact-of-endometrioma-size-on-ovarian-reserve-remains-controversia%E2%80%A6-image-1.jpg Gallery Study diagram comparing average serum AMH levels across different cyst size categories in women with and without endometriomas, including ultrasound images and statistical results. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e940c262-9b77-408d-bc55-c9fdcaf1b905/The-perception-that-hormonal-contraception-causes-weight-gain-is-a-gene%E2%80%A6-image-1.jpg Gallery A scientific infographic titled 'Impact of Hormonal Contraceptives on Weight Gain,' comparing patient perception versus scientific evidence. It includes three panels: Panel 1 showing women discussing contraception concerns; Panel 2 comparing hormonal contraceptive methods (pills, patch, ring), depot medroxyprogesterone acetate injections, and etonogestrel implants, with mechanisms and evidence; Panel 3 detailing mechanisms and misconceptions about fluid retention and fat gain, with diagrams of hormonal pathways and effect on weight. The figure legend notes evidence supports weight neutrality for most methods, except certain variants. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e22202df-2c57-4fac-9a65-8e7b12234cb6/%23%23%23-Practice-Guideline-The-American-Academy-of-Family-Physicians-re%E2%80%A6-image-1.jpg Gallery Infographic titled 'Fezolinetant (Voezah): Nonhormonal Therapy for Vasomotor Symptoms in Menopausal and Perimenopausal Women' covering population context, mechanism of action, drug label and administration, clinical positioning, efficacy summary, safety and monitoring, common adverse events, and other treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0f82a086-5fa0-431a-ac9c-e1494fee0698/Accurate-diagnosis-in-the-postmenopausal-population-is-further-complica%E2%80%A6-image-1.jpg Gallery Flowchart of diagnostic pathway for endometriosis in postmenopausal women, including imaging modalities—transvaginal ultrasonography, MRI, and CT—and details about their uses and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d6fa6890-685e-42e4-85e4-8dc52e747822/BackgroundEndometriosis-is-a-hormone-driven-systemic-inflammatory-condi%E2%80%A6-image-1.jpg Gallery An infographic presenting an overview of endometriosis, study design and meta-analysis methods, and key findings. The first section illustrates symptoms like pain, fatigue, infertility, and endometrial-like lesions, noting it affects up to 15% of women worldwide. The second section details research methods including database searching, quality assessment, and meta-analysis. The third section shows that endometriosis patients have poorer sleep quality with high heterogeneity, persistent association with sensitivity analyses, and clinical implications for pain patterns and targeted interventions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c55667cd-cd82-4b91-9cb2-90220fa4bae6/Discussion-To-the-best-of-our-knowledge%2C-the-present-study-is-one-of-th%E2%80%A6-image-1.jpg Gallery Infographic titled 'Longitudinal Relationships Between Lifestyle Factors and AMH Levels/Decline' with sections on oral contraceptive use, smoking, BMI/central adiposity, coffee/tea consumption, PCOS & menstrual regularity, alcohol, and physical activity. It shows how these factors influence AMH levels and decline over time, including mechanisms, effects, and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/539ed191-7260-4287-9af0-5f2500cbbb94/Does-surgery-for-endometriomas-correct-deformities-and-or-dysfunction-%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Surgery for Endometriomas: Impact on Ovarian Reserve and Fertility Outcomes' divided into five sections. The first section explains endometrioma and clinical dilemmas, showing an illustration of a normal ovary and one with endometrioma, with questions on ovarian dysfunction and fertility. The second section depicts natural fertility outcomes without surgery, indicating 43% natural conception in one year. The third section compares surgical options: cystectomy reduces ovarian reserve (shown with a syringe removing tissue), while alternative hemostasis with suturing/sealants is less harmful and preserves ovarian reserve, with a note on cautious use. Sclerotherapy offers better preservation of ovarian reserve and higher pregnancy rates but should be used selectively. The fourth section addresses long-term considerations, showing high recurrence rates and indicating that repeat surgeries cause greater loss of ovarian reserve, emphasizing unilaterals don’t significantly reduce conception rates if both tubes are patent. The fifth section highlights individualized decision-making based on patient factors like age, ovarian reserve, endometrioma size, bilaterality, semen analysis, coital frequency, and infertility duration, stressing the importance of multifactorial assessment. A cautionary note emphasizes surgery’s modest fertility benefits and the importance of individualized management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7ebd9b50-29a1-4653-8146-56fa8316a958/Does-surgery-for-endometriomas-increase-the-success-and-decrease-the-co%E2%80%A6-image-1.jpg Gallery Comparison of endometrioma treatment: without surgery, healthy oocyte/embryo shown; after surgical removal, fewer oocytes/embryos and lower ovarian reserve highlighted. Includes illustrations of ovaries, endometrioma, and surgical procedure. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/60a79f79-8103-4092-88d0-832b44ac2a24/Does-surgery-for-endometriomas-relieve-suffering-Suffering-in-women-wi%E2%80%A6-image-1.jpg Gallery Diagram showing surgical management of endometriomas. The left side depicts pre-surgery with inflammation, deep lesions, endometrioma, and sensory nerve fibers causing pain. The right side shows post-surgery with removal of endometrioma and residual deep lesions, marked by surgical intervention, which aims to reduce pain and inflammation, but may decrease ovarian reserve. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/66474ed7-9f01-483b-90ec-2364eac68593/Does-surgery-for-endometriomas-save-lives-Is-it-necessary-to-rule-out%E2%80%A6-image-1.jpg Gallery Flowchart illustrating the comprehensive approach to endometrioma surgery and malignancy risk assessment. It includes imaging assessment, clinical and family history, physical examination, serum markers, holistic risk assessment, and decision-making for surgery or early malignancy detection. Features a diagram of a typical and atypical endometrioma, showing their differences and risk factors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2640cae1-db2d-41cb-b115-40581d52844e/Endometriosis-is-an-estrogen-dependent-gynecological-disorder-character%E2%80%A6-image-1.jpg Gallery A scientific infographic titled 'Endometriosis in Postmenopausal Women: Persistence, Incidence, and Challenges,' featuring sections on endometriosis overview, classical disease paradigm, modern understanding, and incidence data and limitations. It includes diagrams of the female reproductive system, ovaries, endometrial glands, and stroma, as well as pie charts and timelines related to disease prevalence and research limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/21dd558a-018e-45a7-ab10-3753cb90cd7d/EVALUATION-AND-COUNSELLING-OF-PATIENTS-WITH-ENDOMETRIOMAS-A-thorough-as%E2%80%A6-image-1.jpg Gallery Infographic depicting the process of evaluating, imaging, planning, and managing endometriosis. Sections include initial assessment with history and ultrasound, MRI and ultrasound for lesion mapping, minimally invasive surgery for treatment, preoperative counseling for personalized care, and multidisciplinary approach with specialists like urologists, colorectal surgeons, and pain experts for patient-centered treatment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6191c35b-cc3a-472a-b5ad-62b37d09b36a/Hot-flushes-and-brain-fog-are-among-the-most-common-symptoms-of-the-men%E2%80%A6-image-1+%281%29.jpg Gallery A scientific infographic titled 'Integrated Mechanisms and Management of Hot Flashes (Vasomotor Symptoms) and Brain Fog in Menopausal Transition.' It explains symptoms, underlying mechanisms, treatment modalities, and brain fog management with illustrations of a woman, brain with chemicals, medications, and graphs showing reduction percentages and analysis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3d4169ca-150e-49b4-a1fd-1e4bf9ae1dd1/Hot-flushes-and-brain-fog-are-among-the-most-common-symptoms-of-the-men%E2%80%A6-image-1.jpg Gallery A detailed infographic on menopause, vasomotor symptoms, treatments, risk management, and holistic approaches. Sections cover symptoms, mechanisms, age-related treatment considerations, FDA-approved therapies, risk factors, timing and formulation of treatments, contraindications, and holistic lifestyle management including exercise, diet, stress reduction, and sleep improvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/390ec476-6b39-441a-a366-8329b517cde7/illMechanisms-The-predominant-mechanism-is-loss-of-endogenous-estrogen%E2%80%A6-image-1.jpg Gallery Diagram showing mechanisms of menopause-related health effects, mortality impact of menopause types, and hormone therapy use timeline and risks. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fdb908cc-4a21-4bc2-a10a-e78a8df0ef45/Later-age-at-menopause-is-consistently-associated-with-longer-lifespan%2C%E2%80%A6-image-1.jpg Gallery Diagram depicting the inverse relationship between age at menopause and mortality risk. It shows four menopause stages—Premature, Early, Typical, and Late—with corresponding age ranges and associated mortality risks, life expectancy, and risk factors, emphasizing that higher age at menopause correlates with lower mortality risk and longer lifespan. It also illustrates mechanistic factors influencing longevity, such as cardiovascular and respiratory diseases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f37dffd7-e256-49bf-bd98-9bd867287f8c/Management-of-endometriosis-in-postmenopausal-women-presents-unique-cha%E2%80%A6-image-1.jpg Gallery Diagram illustrating comprehensive management of endometriosis in postmenopausal women, including surgical management, medical management, lifestyle approaches, risks, and multidisciplinary team involvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/33b55eb2-13d3-4807-b893-d47bf8c764bc/menThe-American-College-of-Obstetricians-and-Gynecologists-%28ACOG%29-recom%E2%80%A6-image-1.jpg Gallery A flowchart detailing cardiovascular care and hormone therapy recommendations for women with primary ovarian insufficiency, including blood pressure measurements, lipid profiling, lifestyle counseling, and ultrasound monitoring for specific conditions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6d1d5b45-efe4-4eb5-9005-48458761ef4a/Non-Pharmacologic-Interventions-Pelvic-floor-physiotherapy-%28PFP%29-is-rec%E2%80%A6-image-1.jpg Gallery Diagram presenting non-pharmacologic treatments for chronic pelvic pain in endometriosis, including pelvic floor physiotherapy, cognitive-behavioral therapy, botulinum toxin A injection, and transcutaneous electrical nerve stimulation, with descriptions of their benefits and effects on pain and quality of life. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/01db6412-9d4e-4db9-aba3-85efefb926c6/Out-of-438-screened-references%2C-14-%282%2C425%2C648-participants%29-were-includ%E2%80%A6-image-1.jpg Gallery Flowchart summarizing meta-analysis on oral contraceptive use and depression outcomes, showing data panels on depression risk, antidepressant initiation, and depressive symptoms scores from studies involving over 2.4 million participants. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/32dd5586-bb4d-42ba-9f6c-9a84614f1c53/Patient-Population-Key-Rationale-Strength-of-Evidence-References-Endome%E2%80%A6-image-1+%281%29.jpg Gallery Chart showing potential patient populations for GLP-1 receptor agonist use in endometriosis, including subgroups with varying levels of evidence support. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4dd8e4a1-8e0f-45de-8071-ff06e3a2463b/Patient-Population-Key-Rationale-Strength-of-Evidence-References-Endome%E2%80%A6-image-1.jpg Gallery Flowchart showing potential roles of GLP-1 receptor agonists in endometriosis patient subgroups. It includes sections on endometriosis plus obesity, deep infiltrating endometriosis with fibrosis, endometriosis plus PCOS overlap, fertility-seeking with nonhormonal pathway, and hormonal therapy—refractory or contraindicated. Each section indicates evidence strength, mechanisms, and treatment implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2aec2deb-cd16-4ed6-aef2-7e13ce1ae5ec/Rationale-for-Potential-Interest-Endometriosis-is-a-chronic-inflammator%E2%80%A6-image-1.jpg Gallery Diagram illustrating the mechanistic rationale and preclinical evidence linking GLP-1 receptor agonists to endometriosis. It shows disease mechanism with ectopic endometrial lesions, macrophages, and fibrosis, and explains the role of GLP-1RA in reducing inflammation, collagen fibrosis, and gland proliferation while alleviating IUA. The diagram also notes obesity/PCOS context, with chronic inflammation, fibrosis, and potential benefits of GLP-1RA in endometriosis. It highlights the lack of clinical models and the uncertain therapeutic role of GLP-1RAs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/df3c0212-8568-419b-8f7e-6b3788b43dd5/Similar-to-premenopausal-endometriosis%2C-one-of-the-main-concerns-in-pos%E2%80%A6-image-1.jpg Gallery Flowchart illustrating risks and features of malignant transformation in postmenopausal endometriosis, comparing pre- and postmenopausal women, including clinical triggers, imaging findings, histotypes, and sites of malignant transformation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c9af1d3b-31d8-4b1b-89c6-5043ec0c6601/Sleep-disturbances-are-highly-prevalent-during-menopausal-transition-an%E2%80%A6-image-1.jpg Gallery A detailed infographic illustrating the relationship between menopausal transition, sleep disturbances, and associated symptoms. It features data on insomnia prevalence, the multifactorial mechanisms involved, pharmacological and non-pharmacological treatments, biological pathways, and future research directions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9f80dcbd-c172-4b42-b71b-3a0b2a395e5c/The-likelihood-of-underdiagnosis-is-higher-in-postmenopausal-women%2C-as%E2%80%A6-image-1.jpg Gallery A medical infographic contrasting endometriosis presentation and risk factors between reproductive-age and postmenopausal women. It highlights cyclical pelvic pain, dysmenorrhea, and infertility in reproductive women, versus non-cyclical pelvic pain, adnexal mass, and urinary disturbances in postmenopausal women. The section explains diagnostic pathways, emphasizing that postmenopausal endometriosis often lacks hallmark symptoms, leading to delayed diagnosis and increased underdiagnosis risk, with clinical implications noted for overlooked cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6ca4ecd9-c84c-4d73-8b74-319df20d97df/The-literature-on-predictors-of-treatment-response-in-refractory-endome%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Predictors of Treatment Response in Refractory Endometriosis.' It outlines clinical and molecular factors influencing therapy success, including graphs, diagrams, and checkmarks indicating positive or negative predictors for pain, sensitivity, and recurrence. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/deb5ac9e-df4a-47f0-816f-4b0b9e96a567/The-pathophysiology-of-endometriosis-remains-incompletely-understood%2C-a%E2%80%A6-image-1.jpg Gallery Diagram explaining the pathophysiology of postmenopausal endometriosis, including sources of estrogen, estrogen's role, lesion origins, and hormone resistance, with detailed subsections and illustrations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8ec2345f-8aae-4d4a-a57b-91698f46adaa/This-meta-analysis-found-that-approximately-30%E2%80%9340%25-of-women-with-endome%E2%80%A6-image-1.jpg Gallery A detailed infographic showing the bidirectional association between endometriosis and endometrial polyps, including epidemiology, risk gradients by endometriosis stage and age, shared pathogenesis factors like genetic predisposition and estrogen sensitivity, clinical implications, and therapeutic targets. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c3397894-19e4-4bb4-8350-91eefb61ae49/What-menopause-tells-us-about-longevity-Timing-matters.jpg Gallery An infographic titled 'How Menopause Timing Shapes Healthspan and Longevity in Women' with four panels explaining menopause and aging. Panel 1 shows menopause timing and lifespan correlation, Panel 2 discusses biological aging mechanisms, Panel 3 details health risks and interventions, and Panel 4 covers ovarian aging pathways and opportunities. The infographic includes diagrams of female aging, organs, DNA markers, and lifestyle factors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dd94d560-2411-43c5-9b44-67e4093f310d/Within-this-substantial-cohort-of-women-with-a-history-of-RM%2C-the-RR-of%E2%80%A6-image-1.jpg Gallery A scientific infographic showing the impact of miscarriage management methods and caesarean section history on future miscarriage risk in women with recurrent miscarriage. It includes cohort overview, management strategies, effects of caesarean section, future miscarriage risk, limitations, and conclusions with success rates of cytogenetic testing, and illustrations of risk percentages. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c677eb41-d5db-49a6-ac66-f360e435badc/0aca7028-3236-464b-9b13-38b02dc3634f.jpg Gallery Timeline diagram of the process of embryo implantation in human fertility, from fertilization to complete implantation over 14 days, including stages like embryo cleavage, blastocyst formation, uterine arrival, attachment, invasion, and integration with maternal tissue. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/afbab723-1129-4207-8050-817aeb698c30/1a816652-3cbb-4d2d-8d23-fac8da171630+%281%29.png Gallery An infographic explaining the definition, symptoms, screening, treatment options, and outcomes of Genitourinary Syndrome of Menopause (GSM). It includes symptoms like vaginal dryness, itching, dyspareunia, urinary urgency, and recurrent UTIs. The diagnostic flowchart guides treatment decisions, highlighting nonhormonal options and FDA-approved medications. Special considerations for breast cancer survivors emphasize personalized oncology input and shared decision-making. Outcomes focus on improved vaginal health, sexual function, urinary control, and overall well-being. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1814b626-2596-48b0-8b69-da71ed2f2704/1a816652-3cbb-4d2d-8d23-fac8da171630.png Gallery Flowchart explaining the definition, symptoms, screening, treatment options, and outcomes for Genitourinary Syndrome of Menopause (GSM), including symptoms like vaginal dryness, itching, dyspareunia, urinary urgency, and recurrent UTIs, and highlighting considerations for breast cancer survivors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/675bf7c4-4598-4188-92c2-0c83f2a5e10d/1c7cdf8b-66a0-4e80-9d33-b7b19fb88cc7.jpg Gallery Diagram illustrating the stages of human embryo implantation, from apposition, adhesion, invasion/penetration, to post-implantation development, showing cellular interactions, signals, and blood vessels. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fb11a20e-6094-4919-9278-7efef25ec8a0/2ce998c5-3c7e-4940-adee-e719226994e7.png Gallery Diagram illustrating five stages of fertilization in human reproduction: 1. Sperm capacitation, showing sperm acquiring fertilization ability and membrane changes. 2. Acrosome reaction, with sperm releasing enzymes to digest the egg's zona pellucida. 3. Sperm-egg fusion, where the sperm penetrates the egg membrane allowing the sperm nucleus to enter the egg cytoplasm. 4. Cortical reaction, triggering release of zona pellucida proteins to prevent polyspermy. 5. Zygote formation, completing fertilization and demonstrating the first mitotic division of the diploid zygote. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/05a79814-2a85-4366-874f-dc18dbd37436/5ddce987-738d-4dba-b5ba-8f4623f9eab5.jpg Gallery Diagram illustrating the impact of estrogen and progesterone hormones on endometriosis, showing phases of tissue proliferation, inflammation, lesion growth, and cell death. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/136ea6a7-8c1a-465a-bccb-0057694f5d2a/21dd74a1-5994-4070-a30d-a4d88f4d83ba.png Gallery A scientific infographic on endometriosis research. It covers epidemiological investigations, basic research mechanisms, clinical presentations, and future directions. Includes diagrams of risk factors like pain and infertility, study population diversity, diagnostic procedures, and suggested future research strategies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/180697b5-9940-4cfd-a453-4a11a233d936/98d7f7d6-96d0-4443-b1d4-ac457f3c502b.png Gallery A detailed infographic on laparoscopic surgery for endometriosis, focusing on its impact on fertility and ovarian reserve. It includes sections on fertility outcomes by disease stage, predictors of postoperative fertility, impact on ovarian reserve, surgery versus IVF/ICSI comparison, and clinical recommendations. Key data, charts, and illustrations are presented to highlight fertility rates, ovarian reserve decline, and surgical guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c1f59bf3-a942-4016-81d2-e59c34e8cf7d/495aad72-ecd2-41fb-aaaf-7ba29eae71b4.png Gallery Diagram showing age-dependent prevalence and clinical pathways of ovarian endometriomas. Includes an age distribution chart, a timeline of morphology and pathophysiology, and a flowchart of clinical management based on patient age and cyst size. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f5393cff-0157-413f-b30b-6973213203f1/732cc053-922b-4249-b5ca-6f448fca3451.png Gallery Infographic illustrating the cardiovascular risk analysis of hysterectomy with bilateral oophorectomy for endometriosis, including risk factors, age-related risk changes, and data from NHSII study showing increased risk of coronary heart disease in women under 46 without estrogen use. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3290368c-6918-4e57-9248-2b844f7a959c/4057de03-4989-4077-9dd6-1117f82e0f8f.png Gallery Bar graph showing age-related variation in surgical indications: pelvic pain, endometriomas, fibroids, and adenomyosis with color-coded age groups: ≤25 years, 25-35 years, 35-45 years, and >45 years. Pelvic pain is most common across all ages, while endometriomas are more frequent in the youngest group. Fibroids and adenomyosis are most common in women over 45. The summary notes pelvic pain as the most prevalent indication, with endometriomas increasing with age and fibroids and adenomyosis most common in women over 45. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/09ca2139-44d1-428f-9f67-abd3ea2120f1/Abstract-Endometriosis-is-a-chronic-gynecological-disease-characterize%E2%80%A6-image-1.jpg Gallery Infographic titled 'Diagnostic Accuracy of a Salivary miRNA Signature in Infertile Women With Endometriosis.' It includes sections on disease overview, symptoms, diagnostic methods, study design, main results, clinical implications, and conclusion banner, providing details about endometriosis detection using salivary miRNA testing. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fd3c3011-a241-4dae-89b7-4f58f1009d1a/ad64a232-b83e-4e8f-95d0-a605f2b304e6+%281%29.png Gallery Infographic on migraines during the menopausal transition, showing causes related to hormonal fluctuations, new symptoms like hot flashes, sleep disturbance, and migraine patterns, treatment considerations including personalized approach with symptom management via vasomotor symptoms, sleep, vascular risk, and treatment options such as hormonal therapy or nonhormonal therapy. The center features a woman with biological icons around her representing symptoms and treatment considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2fe152b4-3b4d-4fb0-b8e1-ec0e03be44db/ad64a232-b83e-4e8f-95d0-a605f2b304e6.png Gallery An infographic titled 'Migraine During the Menopausal Transition: A Plain Language Summary' explains hormonal fluctuations causing migraines, symptoms like hot flashes, sleep disturbance, and migraine patterns, treatment options including personalized approaches with symptom management and hormone therapy, and the need for stronger research in this area. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/63a569a3-bb83-426d-986c-7748b86849d2/adenyosis+poster.png Gallery An informational poster about Adenomyosis Awareness Month in April, highlighting symptoms, importance of awareness, diagnosis, management, and participation tips. Features illustrations of female health issues, medical tools, and floral decoration. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4e69a119-e84f-41f2-9e2d-8139f29210de/afc8f2c7-1a86-43fb-a35b-9a72d283b57a.png Gallery Summary of surgical complexity, histologic progression, clinical implications, and study models related to fibrosis across different age groups, illustrated with graphs and diagrams. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ad693428-f2e1-4605-b574-535fcc0d9081/c297340c-e6a2-4838-8a50-74e8c2ace651.png Gallery Diagram illustrating common endometriosis lesions in the pelvis, showing locations of various implants and adhesions on female reproductive organs and surrounding structures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d6ea1d14-c659-4634-b339-11664148ab0b/canvas-image-1-1774836451851.jpg Gallery Diagram explaining evidence-based hormonal treatment for symptomatic endometriosis, including mechanisms, treatment algorithms, and patient-centered approach. Shows pathophysiology with endometriotic lesions, nociceptive pain, peripheral sensitization, and CNS involvement. Lists hormonal therapy mechanisms like ovarian suppression and clinical results such as improved HRQoL and halted lesion progression. Describes pharmacologic treatment algorithms with first-line therapies (progestogens, estrogen-progestogen combinations), second-line therapies (GnRH agonists and antagonists), and add-back strategies. Emphasizes shared decision-making, clinical expertise, evidence-based strategies, and patient values. Mentions neuro- and nociplastic pain, decision points for treatment failure, and special populations like adolescents and young women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9ac96112-bc46-483a-b340-127a1815c217/canvas-image-1-1774836457965.jpg Gallery Diagram illustrating the impact of female reproductive disorders and insulin resistance on inflammation and reproductive health, highlighting the kynurenine pathway, its dysregulation, and interventions like exercise and improved insulin sensitivity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d8ba705b-d81f-4426-8be1-286f1b857453/canvas-image-1-1774836469230.jpg Gallery Diagram illustrating fertility-enhancing mechanisms of lipiodol hysterosalpingography, showing mechanical debris flushing and immunobiological effects, including lipiodol injection improving implantation conditions. Timeline depicts transition from routine test in the 1970s to fertility enhancer in the 2000s. Clinical evidence indicates repeat lipiodol treatment boosts fertility, especially in endometriosis cases, with potential future research needed for IVF failure cases. Flowchart of lipiodol's benefits as a simple, low-cost fertility treatment and its promising role in endometriosis-related infertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1cf76346-519c-4b83-90a8-78123fd34063/canvas-image-1-1774836485033.jpg Gallery A medical infographic comparing total EVLA and EVLA with mini phlebectomy. It shows treatment methods, outcomes comparison including complication rates, pain levels, recovery time, and return to work, as well as practical notes on procedure training, operation time, and cost. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1aa5cfe2-6002-4f11-a6f3-c0b608003ae5/canvas-image-1-1774836493466.jpg Gallery A detailed infographic explaining a medical procedure for diagnosing and treating uterine polyps. Includes indications and contraindications, equipment setup, step-by-step procedure, and advantages and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fd93fcc9-bb80-4e13-82f5-985a3ff32fd1/canvas-image-1-1775272402327.jpg Gallery A chart discussing non-pharmacological management strategies for PCOS during perimenopause and menopause, including lifestyle modifications like diet and physical activity, chronic pain management, complementary approaches such as supplements, and their effects on mental health and quality of life. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/74d85f48-0968-4d17-b888-fd729f34d843/canvas-image-1-1775273295909.jpg Gallery An infographic titled 'Cardiovascular Risks and Clinical Guidance in Endometriosis: Impact of Hysterectomy, Oophorectomy, and Estrogen Therapy,' divided into four sections. Section I shows the risk overview for women with endometriosis, highlighting baseline risk and increased risk with hysterectomy and bilateral oophorectomy under age 46, and increased risk without estrogen therapy for women aged 46-49. Section II presents guideline-based surgical decision-making, suggesting ovarian conservation lowers cardiovascular risk, mortality, and cancer risk, while hysterectomy with oophorectomy for women under 50 carries substantial risk. Section III discusses informed consent and risks of early hysterectomy, noting increased cardiovascular disease, metabolic, and mental health disorders, especially related to surgical menopause. Section IV describes alternative approaches, like conservative surgical excision to reduce chronic inflammation, improve endothelial function, and avoid surgical menopause or increased cardiovascular risk. A caption emphasizes that estrogen therapy does not fully mitigate cardiovascular risk and that ovarian conservation is recommended when possible, with surgical menopause avoided before age 50. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4b3622a6-6a99-429c-9138-71dcd8869dad/canvas-image-1-1775273303791.jpg Gallery Diagram showing the classification and outcomes of adenomyosis in the uterus. It includes sections on adenomyosis classification (intrinsic and extrinsic), associated disease prevalence, reproductive outcomes, and future directions for clinical impact. The image features a labeled illustration of female reproductive organs, a bar graph comparing disease prevalence, and icons representing clinical procedures and research. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e998ac08-f4f8-4313-bdc8-999f4a02b40c/canvas-image-1-1775273310124.jpg Gallery Diagram illustrating an evidence-based clinical pathway for hormonal management of endometriosis pain. The pathway begins with pathophysiology overview, showing nerve pathways involved in pain. Therapeutic goals focus on reducing ovarian cysts and amenorrhea. The patient-centered decision-making includes clinical expertise, patient preferences, and best evidence to personalize treatment. The treatment ladder starts with first-line hormonal therapy using progestogens and estrogen-progestogen combinations, with options to quickly escalate to second-line GnRH agonists and antagonists if the experience is unpromising. Add-on therapy involves personalized hormonal add-backs. The ultimate goal is therapeutic effect, such as improved quality of life, halted lesion progression, and preserved reproductive potential. Failure criteria involve treatment failure or neuroomodulator notes and drug efficacy limitations. The diagram emphasizes the importance of early intervention in adolescents and young women to improve quality of life and fertility preservation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0762bb09-fcd2-4371-9cca-f752c4c7e47a/canvas-image-1-1775273324709.jpg Gallery Flowchart titled 'MRI-Based Treatment Selection Framework for Adenomyosis: Pharmacological and Minimally Invasive Approaches.' The flowchart shows disease heterogeneity and diagnosis with images of focal and diffuse adenomyosis, MRI-based subtyping indicating localized lesion and diffuse myometrial thickening, patient symptom and severity stratification with icons representing bleeding, pain, severe disease, and fertility desire, treatment modalities including pharmacological treatments (GnRH antagonists, LNG-IUS, Dienogest) and minimally invasive treatments (HIFU, Endometrial Ablation), and a treatment selection framework based on MRI subtype (localized, diffuse, symptom dominance, reproductive intention). https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b8c2b232-43a2-4d9d-ac98-8945a005e8f6/canvas-image-1-1775273333090.jpg Gallery A comprehensive infographic about adenomyosis, including its pathology, clinical manifestations, diagnosis, treatment options, effects on fertility, management during pregnancy, and counseling methods. It features diagrams, pie charts, and medical icons. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/06cc9e9d-7209-490d-8441-24afb989c9e3/canvas-image-1-1775273341174.jpg Gallery Graphic illustrating the use of Lipiodol in hysterosalpingo-graphy (HSG) for fertility assessment, showing real-time monitoring with oil-based contrast, effects of Lipiodol on spontaneous pregnancy rates, mechanisms of action, safety profile, and clinical decision pathways. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e2971d41-f813-4a70-839d-9f30e14b6a81/canvas-image-1-1775273352507.jpg Gallery A detailed infographic depicting the use of menopausal hormone therapy (MHT) in women with endometriosis and hysterectomy from Finnish registry data between 1996 and 2019. It includes illustrated panels of women at reproductive age, postmenopausal women, and surgical menopause, study groups by age, MHT usage statistics, types of MHT with pie charts, and a callout about clinical guidance and knowledge gaps. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/862f54d5-b44d-48b9-a57e-a98fb91ad88a/canvas-image-1-1775273360606.jpg Gallery A scientific infographic detailing clinical and reproductive implications of intrinsic versus extrinsic adenomyosis, including uterine anatomy, review workflow, summary table of findings, ART outcomes, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6af93a14-6659-460b-aa8b-f33cd8668e50/canvas-image-1-1775273377222.jpg Gallery Flowchart outlining management pathways for endometriosis-related subfertility when fertility is a priority. It includes steps such as multidisciplinary assessment, evaluation of endometriosis location (not involving bowel, bladder, ureter), options for surgical excision or ablation, and further management like ovarian endometrioma removal or deep endometriosis surgery. The outcomes focus on improving the chance of spontaneous pregnancy, with additional notes against hormone therapy alone. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f80c7fe7-e02d-4da8-8d22-059aa3d91bc9/canvas-image-1-1775273387389.jpg Gallery Flowchart illustrating management options and clinical considerations for ovarian endometriomas and deep endometriosis, including overview, surgical options, deep endometriosis detail, hormonal treatment, and practice impact. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/92c4e808-9c3b-4f9f-9c96-c698bbc1e10e/canvas-image-1-1775273396773.jpg Gallery Infographic titled 'Chronic Pelvic Pain Disorders: Endometriosis & Adenomyosis' showing a diagram of female reproductive organs highlighting endometrial lesions and adenomyosis, and illustrating reproductive age impact. The section on 'Current Management & Rationale for Lifestyle Focus' depicts standard care with medication and procedures, questioning what works and emphasizing the need for evidence. 'Lifestyle Interventions Evaluated' lists dietary modification, exercise programs, mindfulness, yoga, social connection, and self-management with icons and potential benefits or limited evidence. 'Evidence Gaps & Future Directions' discusses insufficient evidence, underreported adenomyosis, outcomes like quality of life and mental health often unassessed, and calls for larger, high-quality trials and comprehensive lifestyle assessment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4ddb93e9-f8d3-445c-8607-10b56c1a694d/canvas-image-1-1775273421674.jpg Gallery Summary of a study comparing outcomes of SGLT2i plus metformin versus metformin alone in endometriosis patients with T2D. Includes cohort design, primary all-cause mortality results showing significantly lower mortality with SGLT2i+metformin, cardiovascular outcomes with no significant difference, and renal endpoint trends indicating higher risk of severe CKD with SGLT2i. The study involved 3,072 participants over approximately 2.8 years. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cca00053-ea27-4f2c-9f01-af6321f09150/canvas-image-1-1775273429006.jpg Gallery A scientific poster comparing endovenous microwave ablation (EMA) and endovenous laser ablation (EVLA) for treating great saphenous vein (GSV) insufficiency. It shows study background, design, methods, intervention detail, timelines, and endpoints, along with results including occlusion rates, VCSS and AVVQ scores over time, Kaplan-Meier survival plot, and safety profile. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f2b2d490-e528-4ed7-b191-15b3dfb3d4f6/canvas-image-1-1775273440189.jpg Gallery Overview of breast cancer survivorship, treatment options, clinical decision-making, multidisciplinary approach, and summary for managing symptoms and treatment. Includes diagrams of body symptoms, medication options, decision scales, and healthcare team discussions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/269ff1e9-e3fc-4dcc-9cb8-523ed13fb213/canvas-image-1-1775273457321.jpg Gallery Diagram of total endovenous laser ablation for varicose veins, showing guideline overview, historical limitations, technological advances, procedure steps, laser types, and clinical outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/044c33bf-0795-497a-9837-6a7735f246b9/canvas-image-1-1775273466855.jpg Gallery Flowchart illustrating the endovenous laser ablation (EVLA) procedure for varicose veins, including evaluation, vein access, cannulation, anesthesia, vein ablation, and post-procedure care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/698ad910-6e21-43ec-b3d5-5f809cb92025/canvas-image-1-1775273640018.jpg Gallery A detailed infographic depicting the pathophysiology, screening model, barriers, solutions, health and societal impacts of adolescent dysmenorrhea, including diagrams and flowcharts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/832d6eec-96f3-4b05-bf84-01d982c5eb3d/canvas-image-1-1775273652866.jpg Gallery Infographic titled "Impact of Endometriosis on Women's Lives: A Qualitative Study" showing women with endometriosis affecting daily life, work, relationships, sexuality, and family planning, with related icons and color-coded sections. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0eccd038-c75e-4242-bc25-22807e980a61/canvas-image-1-1775342909980.jpg Gallery A scientific infographic displaying a study comparing anthropometric, metabolic, hormonal, and body composition profiles in adolescents with PCOS versus healthy controls. It includes sections on study design overview, key group comparisons in blood pressure, androgen levels, SHBG, and metabolic/body composition, subgroup analyses of lean versus obese PCOS adolescents, correlation/associations between waist circumference, FAI, SHBG, HDL-C, and adiposity, and a take-home message emphasizing early cardiovascular and hormonal changes in adolescents with PCOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ba30f223-7bb0-4119-aca2-d590fb63396b/canvas-image-1-1775342920416.jpg Gallery Diagram showing Utah ENDO study on endometriosis and ovarian endometriomas. Top left: flowchart of study participants, comparing women with no endometriosis, endometriosis, and preoperative serum AMH levels. Top right: illustration of uterus with stages I to IV endometriosis, highlighting stage III and IV with a red bar. Bottom left: bar chart illustrating decrease in AMH levels across no endometriosis, incident endometriosis, and stage III-IV endometriomas, with percentage declines. Bottom right: summary box indicating that stage III-IV and ovarian endometriomas are associated with markedly lower AMH, especially in women with infertility, with trend towards lower AMH in all endometriosis subtypes versus normal pelvis, regardless of surgery. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5b1af00a-be86-471b-a9de-a0da8020aa93/canvas-image-1-1775438868470.jpg Gallery Flowchart comparing surgical outcomes for endometriosis, including evidence summary, disease severity and type, surgical limitations, and considerations, with detailed statistics and diagrams of reproductive organs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8ca6003d-749b-4d98-82b5-71c35ac1048b/canvas-image-1-1775438883703.jpg Gallery A scientific infographic about the use of Lipiodol in endometriosis. It includes four sections: A) Efficacy of Lipiodol versus controls, showing improved pregnancy and live birth rates with Lipiodol; B) Durability of Lipiodol effect, indicating early and transient benefits; C) Real-world outcomes, showing pregnancy rates, live birth rates, and median time to pregnancy under different conditions; D) Clinical decision and mechanistic summary, illustrating indications for surgery and Lipiodol use, treatment mechanisms, and timing. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/35518bf5-6af9-4fa6-842b-2026c3b29e58/canvas-image-1-1775438931722.jpg Gallery A detailed infographic on the relationship between hysterectomy approaches, age, estrogen use, and cardiovascular disease risk in women with endometriosis. The graphic compares no surgery, hysterectomy with bilateral oophorectomy, and hysterectomy with ovarian conservation, highlighting risk levels, hazard ratios, and counseling points. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/09281cb5-02f6-4d1d-9f76-0569e364e9a5/canvas-image-1-1775438948618.jpg Gallery A detailed infographic about cardiovascular risks and clinical guidance in endometriosis. It includes sections on cardiovascular disease risk overview in women with endometriosis, guideline-based surgical decision-making, informed consent regarding hysterectomy, and alternative approaches like conservative surgical excision. The infographic highlights the impact of hysterectomy and oophorectomy with estrogen therapy versus no estrogen therapy on cardiovascular risk, and emphasizes age-related risk distinctions and the benefits of conservative surgery. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fdd3bbc8-8352-4e84-b53e-59a54d8bb5ec/canvas-image-1-1775439197701.jpg Gallery A scientific infographic titled "Localization of Adenomyosis and Its Association with Infertility & Reproductive Outcomes". It includes schematic diagrams of the uterus, bar graphs, and icons illustrating study methods and conclusions. Sections cover adenomyosis classification, disease prevalence, reproductive outcomes, research gaps, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/37267040-8aff-4458-959a-5a61cfb51107/canvas-image-1-1775439210849.jpg Gallery Diagram displaying an evidence-based clinical pathway for hormonal management of endometriosis pain. It includes sections on pathophysiology overview with nerve pathways; therapeutic goals targeting ovarian cysts and amenorrhea; patient-centered decision-making emphasizing personalized treatment based on clinical expertise, evidence, and patient preferences; a hormonal treatment ladder with first-line therapy using progesterogens and estrogen-progesterone combinations, second-line with GnRH agonists/antagonists, and add-on therapy for personalized approaches; therapeutic effects including improved quality of life, halted lesion progression, and preserved reproductive potential; failure criteria with criteria for discontinued treatment; a box on the importance of early intervention in adolescents and young women to improve HRQoL; and notes on the limited efficacy of neuromodulatory drugs for neuropathic pain associated with endometriosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fc4625ad-d03e-4319-894b-72444bb40371/canvas-image-1-1775439285766.jpg Gallery Flowchart of MRI-based treatment selection for adenomyosis, including disease heterogeneity, symptom stratification, treatment modalities, and framework. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/57e6d00c-f10d-4451-bd0e-14871476b2b8/canvas-image-1-1775439294966.jpg Gallery An infographic explaining adenomyosis, including its pathophysiology, clinical manifestations, diagnosis, treatment options, impact on fertility, management during pregnancy, and counseling. It shows diagrams of the uterus, ultrasound and MRI imaging, statistics on symptoms and reproductive outcomes, and illustrations of medical and surgical treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/027727f2-82ed-44ac-ae99-696a6e670f68/canvas-image-1-1775439387867.jpg Gallery An infographic about Lipiodol in hysterosalpingo-graphy (HSG) and its effects on infertility treatment. It explains HSG procedure, compares oil-based and water-based HSG, highlights recent study results, discusses mechanisms of fertility enhancement, safety profile of Lipiodol HSG, and clinical decision pathways for women with infertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/632d0fc2-ce0c-4eb7-b7c7-58c7b2d23134/canvas-image-1-1775439496329.jpg Gallery Chart illustrating menopausal hormone therapy (MHT) use in women with endometriosis and hysterectomy, based on Finnish registry data from 1996 to 2019. The image includes an overview panel showing reproductive age woman, postmenopausal woman, and different surgical procedures like hysterectomy and bilateral oophorectomy. Study groups are divided by age and endometriosis status, with reference groups. Bar charts display MHT usage percentages: 90% for women ≤45 years with endometriosis, 70% for women >45 years with endometriosis, and 40% for the reference group. Pie charts show that 80% of women under 45 receive estrogen-only therapy and 60% of women over 45 receive combined estrogen-progestogen therapy, with increasing combined therapy over time. A note discusses clinical guidance on progesterone and therapy risks/benefits. The conclusion emphasizes women with endometriosis are more likely to use MHT post-hysterectomy, estrogen-only therapy is most common, combined therapy is increasing, and evidence on MHT risks/benefits is limited. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0ae94e27-f39a-48a3-837d-7616a8fe638e/canvas-image-1-1775439525329.jpg Gallery Flowchart summarizing clinical and reproductive implications of intrinsic versus extrinsic adenomyosis, including anatomical localization, systematic review workflow, key findings, ART outcomes, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/67731578-77b4-4c52-929e-47801fae1a85/canvas-image-1-1775439667844.jpg Gallery Flowchart titled 'Management Options and Clinical Considerations for Ovarian Endometriomas and Deep Endometriosis.' It includes sections on overview, surgical options, deep endometriosis detail, hormonal treatment, and practice impact. The overview discusses ovarian endometrioma larger than 3 cm and deep endometriosis affecting bowel, bladder, or ureter. Surgical options compare cystectomy and ablation/drainage, showing no significant difference in pregnancy rate. Deep endometriosis detail suggests discussing impact on pregnancy outcomes. Hormonal treatment includes combined medication with laparoscopic surgery, with outcomes on pregnancy rate and live birth rate. Practice impact shows balanced options with minimal resource impact. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/bbc77a85-05ee-4370-a52d-d7c32b8c6506/canvas-image-1-1775439693629.jpg Gallery A comprehensive infographic on managing chronic pelvic pain disorders, focusing on endometriosis and adenomyosis. It includes diagrams of the female reproductive system highlighting endometrial lesions and adenomyosis, an overview of current standard care practices, potential lifestyle interventions like dietary modifications, exercise, and mindfulness, as well as their potential benefits and limited evidence. The infographic emphasizes social connection and self-management and discusses evidence gaps and future research directions in lifestyle modifications for pelvic pain related to endometriosis and adenomyosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6c316a52-22e5-4618-8aef-e918a773f79c/canvas-image-1-1775439771695.jpg Gallery Infographic showing a study comparing SGLT2i plus Metformin versus Metformin alone in endometriosis patients with T2D, highlighting reduced all-cause mortality and cardiovascular outcomes, with a renal endpoint trend toward higher risk of severe CKD with SGLT2i. The panels include study design, mortality rates, cardiovascular outcomes, and renal risk. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/acf4ee0d-1ab0-439e-a249-a1bf92d4234b/canvas-image-1-1775439806226.jpg Gallery A scientific infographic presenting a study comparing endovenous microwave ablation (EMA) and endovenous laser ablation (EVLA) for GSV insufficiency, including background, methods, intervention details, results with graphs showing occlusion rates, scores, Kaplan-Meier survival, safety profile, and conclusion. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1fa13c07-cea3-4350-840f-2e3a701e8f50/canvas-image-1-1775439839382.jpg Gallery A detailed infographic titled 'Hormone Therapy for Premature Ovarian Insufficiency' with sections on therapy overview, recommended regimens, safety routes, and monitoring. It includes diagrams of the human reproductive system, drug dosing information, and icons illustrating therapy and safety considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/692f0e38-f952-415b-8339-5b4efbcf8092/canvas-image-1-1775439848329.jpg Gallery Infographic about premature menopause and increased cardiovascular disease risk, showing risk levels by age, mechanisms of increased risk such as body fat redistribution, reduced glucose tolerance, dyslipidemia, elevated blood pressure, hyperlipidemia, hypertension, type 2 diabetes, endothelial dysfunction, and vascular inflammation, and clinical management guidelines including hormone therapy, monitoring, lifestyle modifications, and cholesterol guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5fae8734-d341-46e9-bf80-1e68be4e7b40/canvas-image-1-1775439860427.jpg Gallery Chart titled 'Migraine Across the Menopausal Transition: Pathophysiology, Comorbidities, and Therapeutic Strategies'. It includes sections on migraine epidemiology and hormonal influence, migraine subtypes and stroke risk, midlife comorbidities, therapeutic approaches and evidence, and clinical recommendations. The chart features icons of people, hormones, a brain, pills, and medical symbols, with color-coded sections and arrows illustrating relationships and processes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9b0793ec-001c-43ff-a51b-92609f181d86/canvas-image-1-1775439876758.jpg Gallery Diagram summarizing a study on postmenopausal women, showing cohort size, study timeline, and health transitions; illustrating menopause age groups from premature to normal, and a multi-state progression model from healthy to first chronic disease, multimorbidity, and death; highlighting key findings such as increased risks associated with menopause and age. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d16a521a-c92e-466c-b1e1-de03718530fd/canvas-image-1-1775439891859.jpg Gallery Flowchart of study design for laparoscopic surgery in women, showing screening, surgery, and classification into iSPE or no endometriosis groups, with data on pain outcomes and predictors, timeline assessment graphics, symptom subtypes, and key findings. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d0d94bc5-3ef3-4cb8-826e-e5fdaf89a240/canvas-image-1-1775439908825.jpg Gallery A detailed medical infographic titled 'Hysteroscopic Diagnosis and Management of Adenomyosis: Outpatient Approach' with sections on patient symptoms, imaging, hysteroscopic visualization, classification, biopsy technique, outpatient treatment, and future directions, including illustrations, diagrams, and charts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/385fc89f-ce7f-4a9b-8d98-0753235ba2c1/canvas-image-1-1775439925276.jpg Gallery Flowchart illustrating the diagnostic and therapeutic role of hysteroscopy in adenomyosis, including clinical overview, diagnostic modalities, hysteroscopic findings & treatment, and future directions; features illustrations of the uterus and hysteroscope. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f0d12b95-8155-4b2e-b0c4-ccda7be2d056/canvas-image-1-1775439978491.jpg Gallery Infographic outlining IVF process and alternatives, including overview of IVF stages, barriers, diagnostics, and options such as ovulation medications, intrauterine insemination (IUI), lifestyle interventions, and structured support programs. It also compares costs, invasiveness, and success rates of various fertility treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cdfa2c28-179b-4c99-8cd3-48d05d055685/canvas-image-1-1775439992490.jpg Gallery A scientific infographic showing the risk of endometriosis, adenomyosis, and related symptoms in female offspring conceived by assisted reproductive technology (ART). It includes study design overview, main results with adjusted hazard ratios, and comparison between groups. Key findings indicate increased risks of endometriosis, menstrual pains, pain during intercourse, and heavy menstrual bleeding in ART-conceived female offspring. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f7615cd4-920c-4996-8539-b93af2fb5d69/canvas-image-1-1775440061157.jpg Gallery A scientific infographic from the Utah ENDO Study showing that endometriosis and ovarian endometriomas are associated with lower levels of anti-Müllerian hormone (AMH). The top left section illustrates the study design comparing women with no endometriosis, endometriosis, and preoperative serum AMH quantification in women aged 18-44. The top right diagram depicts the female reproductive system with stages of endometriosis severity (minimal to severe) and highlighted association with stage III-IV. The bottom left bar graph shows AMH levels across different endometriosis statuses, with a notable reduction in AMH in stage III-IV endometriomas. The bottom right box emphasizes that stage III-IV endometriomas are linked to markedly lower AMH and that endometriosis is most strongly associated with infertility. The overall message is that all endometriosis subtypes trend toward lower AMH compared to normal, regardless of surgical intervention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4f96ec07-f99c-4250-980d-83b9ce50585d/canvas-image-1-1775617215703.jpg Gallery A clinical infographic presenting a study on intrauterine synechiae, showing study design, cumulative incidence, clinical implications, and risk factors. It features diagrams of the female reproductive system, hospital and patient icons, statistical data, and risk factor illustrations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c68532f2-0a2a-4903-b780-88fb35e98d5c/canvas-image-1-1775617222996.jpg Gallery A medical infographic showing a study comparing cure rates of chronic endometritis associated with endometrial polyps after treatment with conventional resectoscope versus tissue removal device. It includes diagrams of the female reproductive system, flowcharts of patient groups, and data on cure rates. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f4664f11-c438-4644-a73e-c26cbaf06647/canvas-image-1-1775617233594.jpg Gallery Diagram showing shared placenta-specific genetic associations underlying uterine fibroids and endometriosis, including disease background, study workflow with GWAS and multi-trait analysis, major results of shared and placenta-specific genes, interpretation and model, and tissue comparison. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/50b27eae-3164-4382-a8b9-c69633dc4311/canvas-image-1-1775617244312.jpg Gallery A detailed infographic about hormone therapy for premature ovarian insufficiency, including therapy overview, recommended regimens, safety considerations, and monitoring guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7a7d3dbd-9b15-481a-b67c-f4edc5f88e6f/canvas-image-1-1775617251780.jpg Gallery An infographic titled "Premature Menopause and Increased Cardiovascular Disease Risk: Pathophysiology and Clinical Management". It details menopause age groups and associated cardiovascular risks, mechanisms of increased risk, and clinical management guidelines including hormone therapy, monitoring, lifestyle modifications, and cholesterol guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f6b1c8ae-7eb0-40ca-8757-fe1335aa2a22/canvas-image-1-1775617260745.jpg Gallery Infographic depicting migraine across the menopausal transition, including epidemiology, subtypes, comorbidities, therapeutic approaches, and clinical recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5988b71f-1c9d-42fc-b313-a739fda9746d/BackgroundChronic-venous-insufficiency-%28CVI%29-is-a-prevalent-vascular-di%E2%80%A6-image-1.jpg Gallery Comparison chart of outcomes for NBCA, EVLA, and RFA treatments for chronic venous insufficiency, including study overview, key results such as vein occlusion rate, procedure time, pain scores, return to activities, complications, and conclusions about procedure effectiveness, durability, procedure time, pain, recovery, and recommendations for technique selection. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7964fcf3-2f41-4dc4-b144-177a1b8d0eba/export-1779077153018.png Gallery A chart showing the 2023 international evidence-based guidelines for diagnosing polycystic ovary syndrome (PCOS). It includes endorsed organizations, criteria for diagnosis requiring any two of three criteria, key simplifications, and recent updates including the use of AMH as an alternative diagnostic criterion. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6db4ce32-6fb4-4fc4-b13c-130bafbf85c4/export-1779077162461.png Gallery 2023 international evidence-based guideline for diagnosing polycystic ovary syndrome (PCOS); endorsed by 39 organizations including Endocrine Society, ESHRE, and ASRM; criteria include clinical/biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology or elevated serum anti-müllerian hormone; updated in 2023 with AMH as an alternative to ultrasound; key points highlight when both hyperandrogenism and ovulatory dysfunction are present, diagnosis is simplified, and ultrasound/AMH testing may be unnecessary. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/12065c9f-b38f-4026-b018-7e76950389eb/export-1779094432083.png Gallery A scientific infographic titled 'Hyperandrogenism: Key Diagnostic Markers' describing clinical and biochemical hyperandrogenism, including guidelines for testing testosterone and free testosterone, and the diagnostic accuracy of key markers in PCOS, with a bar graph showing pooled sensitivity percentages for free testosterone (70.6%), total testosterone (36.3%), and mFG threshold (4-6). https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/244d7e7b-0ac0-4c2a-9719-678607e17acb/export-1779094635856.png Gallery Flowchart illustrating diagnostic criteria for ovulatory dysfunction and primary amenorrhea. It details age groups, menstrual cycle patterns, and diagnostic steps including hormone testing and timing. Primary amenorrhea by age 15 or after three years post-telarch. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/55a8dd44-3bd9-471c-9019-e1b3d529bbce/export-1779094690865.png Gallery Infographic explaining criteria for ovulatory dysfunction, including normal puberty transition, diagnostic criteria, and key takeaways, with statistics on anovulation and methods of confirming ovulation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/41cb45cd-c6b4-43a2-ab6f-574d307908a0/export-1779094775668.png Gallery Chart of 2023 updated PCOM ultrasound thresholds for transvaginal and transabdominal approaches, detailing markers, thresholds, and clinical performance metrics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ae08d70a-5df3-49a6-992f-7f7841cd020f/export-1779094812662.png Gallery A chart titled '2023 Updated PCOM Ultrasound Thresholds' showing ultrasound approaches, markers, and thresholds for ovarian assessment, including transvaginal and transabdominal methods, with diagnostic criteria related to follicle number, ovarian volume, and follicles per section, along with accuracy metrics for the Follicle Number Per Ovary marker. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0bf35cf3-81bb-4785-be17-b1145ea09736/export-1779094915682.png Gallery Comparison infographic of ultrasound and serum AMH as guidelines for PCOM, highlighting the criteria, sensitivity, specificity, and key considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f431ebdf-a390-4ab4-ac7b-1b62b63ae2ea/export-1779094967678.png Gallery An infographic explaining AMH as an alternative to ultrasound for diagnosing PCOM in adults, with details on serum AMH and ultrasound, accuracy statistics, and usage guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dab7e1ff-ada2-4194-858d-7f6f107bb071/export-1779095058865.png Gallery Diagram showing four distinct metabolic risk profiles for PCOS based on Rotterdam criteria: Phenotype A (classic/full), Phenotype B (classic), Phenotype C (ovulatory), and Phenotype D (non-hyperandrogenic). Each profile presents features, metabolic risk levels, prevalence, impact, controversy, and clinical recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a445190e-eade-4e03-8105-ecebc64170ec/export-1779095116562.png Gallery Chart detailing Rotterdam-based phenotypes of PCOS, including criteria and risk levels for four types: Classic/Full, Classic, Ovulatory, and Non-hyperandrogenic, with associated features, metabolic risks, and prevalence estimates. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d9eddbef-cbaf-4369-9492-97757b026750/export-1779095255290.png Gallery 2023 guideline infographic for adolescent-specific criteria for PCOS diagnosis, detailing diagnostic steps, core requirements, times and ultrasound use, exclusions, and management for incomplete cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d4ec934f-c8c8-4428-9b41-23578f8e3cd3/export-1779095326196.png Gallery 2023 PCOS guideline infographic for adolescent-specific diagnosis, detailing diagnostic criteria, principles, and key reminders for managing PCOS in adolescents. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7acc046b-eeeb-4097-9f2c-c5a605e5a480/export-1779095426713.png Gallery A chart titled 'Mandatory Exclusions in Diagnostic Frameworks' listing conditions like nonclassical congenital adrenal hyperplasia, thyroid disease, hyperprolactinemia, Cushing syndrome, androgen-secreting tumors, primary ovarian insufficiency, and hypothalamic amenorrhea. It details recommended screening tests and key notes for each condition, including hormones like 17-hydroxyprogesterone, TSH, prolactin, testosterone, DHEAS, FSH, estradiol, LH, and estradiol, with a note on routine biochemical exclusion and additional testing guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/98f28ad6-8af9-4672-8559-a3724fecff4e/export-1779095477633.png Gallery A chart titled 'Mandatory exclusions in diagnostic frameworks' listing conditions like nonclassical congenital adrenal hyperplasia, thyroid disease, hyperprolactinemia, Cushing syndrome, androgen-secreting tumors, primary ovarian insufficiency, and hypothalamic amenorrhea, along with recommended screening tests, key notes, clinical clues, and routine biochemical exclusions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8d6f54bd-cad9-42fd-a9d9-665528b4ab56/export-1779095616328.png Gallery Diagram illustrating the relationship between insulin resistance and PCOS, showing prevalence, core pathophysiology with impaired GLUT4 translocation, effects like hyperinsulinemia and hyperandrogenism, reproductive dysfunction, and diagnostic guidelines including surrogate indices and metabolic screening. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d7bb8f11-659e-4f39-902d-bb21fa05285b/export-1779095727072.png Gallery Educational infographic on the role of insulin resistance in PCOS, showing prevalence, surrogate indices, pathophysiological role, and diagnostic guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5f2ea999-85de-423c-a267-cc8f44cef5eb/export-1779095864393.png Gallery Infographic explaining the pathophysiology of insulin resistance in PCOS, highlighting core mechanisms involving hyperinsulinemia, hyperandrogenism, liver sex hormone-binding globulin production, and reproductive dysfunction, along with guidelines for measuring and diagnosing insulin resistance. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c2ed2ea8-f294-4834-86a5-27496d97c955/export-1779096036161.png Gallery A chart showing 2023 international guidelines for diagnosing PCOS in adults and adolescents. Adults need 2 of 3 criteria: hyperandrogenism, ovulatory dysfunction, and polycystic ovary morphology. Adolescents need both hyperandrogenism and ovulatory dysfunction, but PCOM/AMH should not be used for diagnosis in adolescents. Key updates include raised follicle threshold to 20 follicles per ovary and phenotyping for metabolic risk. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/df0c48ac-f6e4-4b9d-92df-71706418eb8c/export-1779096042625.png Gallery Infographic of 2023 international guidelines for diagnosing PCOS. It compares criteria for adults aged 18+ and adolescents under 18. Adult diagnosis requires 2 of 3 criteria: hyperandrogenism, ovulatory dysfunction, PCOM/AMH. Adolescents require both hyperandrogenism and ovulatory dysfunction. Key updates include raising follicle threshold for follicle count to 20 and using AMH as an alternative in adults. PCOM/AMH should not be used for diagnosing adolescents. The infographic emphasizes early risk assessment through phenotyping and metabolic risk management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/bacfb270-0058-406c-9656-c6d5e7ab728c/export-1779096465048.png Gallery An infographic explaining the diagnostic criteria and pathways for Polycystic Ovary Syndrome (PCOS). It covers adult diagnosis with two out of three criteria - hyperandrogenism, ovulatory dysfunction, and PCOM or high AMH, and adolescent diagnosis with stricter rules. It highlights excluded tests, risk categories, four phenotypes, insulin resistance, and metabolic health considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a3e0625-f9b2-4b5e-b7b9-bdede8582725/export-1779096565053.png Gallery Infographic explaining Polycystic Ovary Syndrome (PCOS). It includes an illustration of a woman, a diagram of the female reproductive system, and sections titled 'Adult Diagnosis,' 'Adolescent Diagnosis,' 'The Four PMOS Phenotypes,' and a note on insulin resistance. The infographic outlines criteria for diagnosis, symptoms, and tests for PCOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/01393000-20a3-4114-b257-97b366aa45c9/export-1779097244822.png Gallery An infographic explaining insulin resistance in PCOS, highlighting key statistics, cellular mechanisms, liver effects, phenotypes, and IR severity, with diagrams of skeletal muscle and liver functions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a451dd72-49e2-4407-be88-01dabcedd7c2/export-1779097258488.png Gallery Diagram illustrating insulin resistance in PMOS, focusing on cellular mechanisms involving skeletal muscle, insulin signaling, and liver. Features control and PMOS conditions, phenotypes, and clinical guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/10c96ba2-dc6e-4e08-a153-dddf0f5f4697/export-1779128129424.png Gallery Clinical summary infographic on testosterone therapy for postmenopausal women, focusing on hyposexual sexual desire disorder, its benefits, and guidelines for treatment including biopsychosocial assessment, formulation, monitoring, and safety considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0a594568-a16f-4ff6-8505-aa989fe6e48e/export-1779128239888.png Gallery Infographic titled "Testosterone Therapy for Postmenopausal Women: Clinical Summary" explains indications, benefits, and guidelines for testosterone therapy. Features include a testosterone decline graph, a section on therapy benefits, warnings, prescribing recommendations, and contraindications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b324b5bf-eaac-4463-97fa-932b641f8683/Abstract-BackgroundTelangiectasia-and-reticular-veins-are-usually-not-a%E2%80%A6-image-1.jpg Gallery Flowchart comparing efficacy of liquid versus foam sclerotherapy with/without herbal gel for telangiectasia and reticular veins, showing study design, treatment groups, and outcome results with high resolution, better patient satisfaction, faster improvement, and minimal adverse events in foam sclerotherapy with herbal gel group. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e0b9cdc3-a3e3-469e-ba9d-68482feab9c4/Abstract-Introduction-Whether-endovenous-thermal-ablation-%28EVTA%29-can-b%E2%80%A6-image-1.jpg Gallery A scientific infographic about early endovenous thermal ablation in CVI with SVT, showing study timeline, intervention methods, outcomes, and follow-up details. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6eee2e4a-9029-4d89-aede-5b2a07183616/Abstract-Objectives-Endovenous-laser-ablation-%28EVLA%29-of-the-great-saph%E2%80%A6-image-1+%281%29.jpg Gallery A detailed medical infographic comparing simultaneous versus delayed venous vein treatment following endovenous laser ablation, including study design, outcomes, adverse effects, patient satisfaction, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/de6c82e6-e0c4-4d27-845b-21b8f0897077/Abstract-Objectives-Endovenous-laser-ablation-%28EVLA%29-of-the-great-saph%E2%80%A6-image-1.jpg Gallery Chart comparing outcomes, techniques, and benefits of simultaneous versus delayed venous vein treatment following endovenous laser ablation (EVLA) with illustrations of study design, key results, clinical implications, and patient satisfaction. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f770a1da-6ea5-45f5-9710-8f15c4400e55/Endometriosis%2C-particularly-ovarian-endometrioma%2C-is-associated-with-a%E2%80%A6-image-1.jpg Gallery Diagram illustrating endometriosis and ovarian cancer risks, molecular links, diagnostic challenges, and clinical management strategies, including hormonal therapy, surgical intervention, prophylactic surgery, and personalized multidisciplinary care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8f3cc488-cdd0-408e-be85-acf78e535222/export-1779075213151.png Gallery Packaging of Trimbow inhaler with a digital world map in the background, highlighting global reach, and text detailing its triple therapy for respiratory health. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a4850b6-699e-4232-b32b-fa0b445b2a07/Impact-of-Laser-Wavelength-on-Outcomes-of-Flush-Endovenous-Laser-Ablati%E2%80%A6-image-1+%281%29.jpg Gallery Diagram comparing lower limb anatomy using 1470 nm and 1940 nm lasers, showing differences in energy delivery, complications, pain scores, early occlusion, and postoperative improvement scores; includes graphs and data summaries. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f1fbef28-ced1-4e5f-83c3-1957a4f9a371/Impact-of-Laser-Wavelength-on-Outcomes-of-Flush-Endovenous-Laser-Ablati%E2%80%A6-image-1.jpg Gallery Diagram comparing lower limb anatomy and effects of 1470 nm and 1940 nm lasers. Includes illustrations of veins, complications, pain scores, and postoperative improvement scores. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/337a0138-ac58-40f1-9ee4-48dd61cc763a/In-this-issue-of-CMAJ%2C-research-by-Milne-and-colleagues-shows-an-increa%E2%80%A6-image-1.jpg Gallery An infographic discusses barriers and solutions in endometriosis care, highlighting current burdens like diagnostic delays, symptoms, and under-recognition, barriers such as limited imaging access and need for surgery, and solutions involving empowering primary care, advanced imaging, and specialized multidisciplinary teams to improve patient outcomes in Canada. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9bf068e9-c367-4b77-b641-99064fa51079/Clinical-Efficacy-of-GLP-1-Receptor-Agonists-for-Ovulation-in-PCOS-Evid%E2%80%A6-image-1.jpg Gallery A detailed infographic explaining the clinical efficacy and positioning of GLP-1 receptor agonists for ovulation induction in PCOS, comparing evidence, clinical algorithms, safety considerations, and key gaps in data. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ab0c50af-c935-48b6-a53b-9ae6f60d3bf4/Context-and-the-case-for-a-new-name-The-term-polycystic-ovary-syndrome%E2%80%A6-image-1.jpg Gallery Infographic explaining the rationale for renaming Polycystic Ovary Syndrome (PCOS) to address misconceptions and multisystem impact. It shows the difference between a misnomer of polycystic ovary and a normal ovary, lists multisystem features like endocrine, metabolic, dermatological, reproductive, psychological aspects, and highlights misconceptions, delayed diagnosis, poor communication, stigma, and distress, with emphasis on fertility. It discusses the consensus for a new, accurate, multisystemic name supporting care, research, and adoption, and illustrates research and policy challenges due to complexity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4a42bea4-c921-40e5-852a-8d76d82fb0c9/export-1778467449755.png Gallery A detailed chart showing endometrial histology across the menstrual cycle, including phases from menstrual to premenstrual, with diagrams and descriptions of glands, stroma, vessels, endometrial thickness, and hormone levels. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9be8203e-034b-43a1-aef2-9858c7e975ed/export-1778467459771.png Gallery Histological chart of endometrial changes throughout the menstrual cycle. Shows different phases: menstrual, proliferative, and secretory, with detailed microscopic images at high power. The chart illustrates glands, stroma, and vessels in the endometrium. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/38a519ef-754e-425b-8463-d65e5f99cd72/export-1778468102906.png Gallery A detailed infographic illustrating the mechanisms of weight-independent GLP-1 receptor action on the hypothalamic-pituitary-gonadal (HPG) axis, including central, pituitary, ovarian, and peripheral mechanisms, and their effects on reproductive functions in women with PCOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3792ee8f-c7aa-4c79-9a3c-092df4a02962/export-1778468110755.png Gallery Infographic detailing the weight-independent GLP-1 RA action on the HPG axis in lean PCOS, illustrating mechanisms across hypothalamic/central, RAS1/RAS4/AKT/GnRH, ovarian/peripheral, pituitary, and reproductive evidence, with implications for future trials. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/123d183c-927b-48d1-afd7-c2862fd2197b/export-1778468571671.png Gallery Diagram explaining PCOS follicular dynamics and follicle development stages, comparing normal ovary and PCOS ovary, with illustrations of follicle stages, immature follicles, thickened stroma, and key features. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3b59829c-d001-490c-aea9-97b9a7deceaf/export-1778468577929.png Gallery Diagram comparing normal ovary with PCOS ovary, showing follicular development stages, immature small follicles arranged peripherally, and thickened collagen-rich stroma in PCOS ovary. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/36eae8f7-52e7-4585-bf8f-739e12ff3f65/Gemini_Generated_Image_zh9ynyzh9ynyzh9y.png Gallery An infographic about women's health at Links Clinic Edmonton, highlighting issues like PCOS and uterine bleeding, with sections on reproductive health, weight management, mental health, and compassionate care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/91747cca-b4d8-4291-bdc0-b91fdff3aaec/Highlights-%E2%80%A2-The-use-of-OCs-was-associated-with-a-31%25-increased-relativ%E2%80%A6-image-1.jpg Gallery Flowchart of a meta-analysis on oral contraceptives and depression outcomes in women, including population characteristics, outcomes, subgroup analysis, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e5a3816d-39ff-43bf-b421-9f61319caeab/How-should-endometriosis-be-diagnosed-in-women-undergoing-infertility-e%E2%80%A6-image-1.jpg Gallery Flowchart outlining the diagnostic approach for endometriosis in women with infertility, including steps from initial clinical suspicion, assessment, imaging, laparoscopic evaluation, biomarker testing, to final summary and management recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/06b1bd61-a6cf-41d4-b31b-03853159651f/Insulin-resistance-is-documented-in-clamp-studies-in-75%25-of-women-with%E2%80%A6-image-1.jpg Gallery A scientific infographic titled "Insulin Resistance and GLP1-RAs in PCOS Pathogenesis and Treatment" illustrates six sections on PCOS, molecular defects, treatment approaches, mechanisms of GLP1-RAs, fertility improvement, and clinical promise, with diagrams and icons explaining the processes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5916af3c-0080-4051-868c-ca013192485c/Introduction-Flush-endovenous-laser-ablation-%28fEVLA%29-has-been-introduc%E2%80%A6-image-1.jpg Gallery Diagram comparing 1470 nm and 1940 nm laser procedures for vein treatment, showing procedural steps, complications, energy density graphs, recurrence data, and clinical outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/91ad790a-34eb-4421-bf74-304638370cf6/Key-messages-%E2%80%A2-Polycystic-ovary-syndrome-affects-more-than-170-million%E2%80%A6-image-1.jpg Gallery Infographic explaining the renaming of Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome, detailing the global consensus process, anticipated impacts, and implementation efforts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0c128def-3dbd-445c-b265-74b99e952517/Key-points%E2%80%A2-Endometriosis-associated-infertility-is-multifactorial-and%E2%80%A6-image-1.jpg Gallery Infographic titled 'Endometriosis-Associated Infertility: Mechanisms, Diagnosis, and Treatment' with five sections explaining the impact of endometriosis on fertility. Section 1 shows hormonal impact and reproductive outcomes. Section 2 depicts clinical evaluation with ultrasound and MRI diagnostics. Section 3 illustrates mechanisms like inflammation and oxidative stress. Section 4 describes ovarian endometrioma and post-surgery ovarian reserve reduction. Section 5 outlines treatments such as hormonal therapy, reproductive gain, and ovarian preservation, mentioning surgery for women only. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/710cde10-1e5b-4121-84f1-e70b8aee083f/Mechanisms-of-Ovulation-Restoration-Weight-Dependent-and-Weight-Indepe%E2%80%A6-image-1.jpg Gallery Diagram illustrating mechanisms, treatment comparison, safety, and clinical management of GLP-1 receptor agonists in ovulation restoration for PCOS. Sections include pathway of GLP-1 RA, comparison with standard therapies, safety considerations, and a clinical algorithm for PCOS management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/88f281b2-0173-4cde-8f95-81240514d4fc/Objective-This-debate-paper-aims-to-examine-the-effects-of-glucagon-li%E2%80%A6-image-1.jpg Gallery Diagram illustrating the impacts of GLP-1 receptor agonists on fertility, contraception, and pregnancy. It includes sections on fertility effects such as weight loss and improved insulin sensitivity, contraceptive efficacy through oral pills with fewer GI side effects using long-acting reversible methods, and pregnancy outcomes recommending washouts before conception. The diagram shows process flow with blue arrows, green checkmarks indicating reliability, and red Xs for cautions, featuring icons of a woman, man, doctor, and various medical devices. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/77b95e8a-530f-4165-b380-37d0bc3574ee/omething-is-quietly-reshaping-reproductive-medicine-%E2%80%94-and-many-patients%E2%80%A6-image-1.jpg Gallery A comprehensive infographic explaining how GLP-1 receptor agonists are reshaping PCOS management and reproductive outcomes. It details the pathophysiology of PCOS, including insulin resistance, androgen levels, and irregular cycles. The infographic illustrates how GLP-1 receptor agonists improve insulin sensitivity, decrease ovarian androgens, and restore ovulation, leading to menstrual regularity. It also highlights the reproductive outcomes, such as increased chances of pregnancy and the importance of timing GLP-1 before conception, while warning that unplanned pregnancies may result from these treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/53445f9d-a335-4294-bbb4-89e304d0c3ca/Polycystic-ovarian-syndrome-%28PCOS%29-is-the-most-common-endocrinopathy-in%E2%80%A6-image-1.jpg Gallery Diagram comparing traditional therapy with estradiol-progesterone and incretin mimetics for PCOS, showing effects on ovarian morphology and GIP activity, including classes of incretin mimetics, outcomes like weight loss and insulin sensitivity, and a note on further research needs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9e505a30-f204-4066-9d22-84941dd0141f/Recommendations%E2%80%A2-Management-of-endometriosis-associated-infertility-sho%E2%80%A6-image-1.jpg Gallery Flowchart depicting an integrated management algorithm for endometriosis-associated infertility. It includes assessment of disease phenotype, reproductive goals, and additional factors. The approach emphasizes structured clinical and imaging procedures, prioritizes laparoscopic excision of superficial lesions, and selective excision of ovarian endometriomas based on specific criteria. It recommends counseling for fertility preservation in at-risk women and prioritizing ART for specific indications such as prolonged infertility, diminished ovarian reserve, advanced disease, tubal damage, or failed prior surgery. No hormonal treatment is used for fertility improvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/96ee2118-1c5e-4bf4-a5d5-b5a80bee4582/The-preclinical-evidence-for-weight-independent-mechanisms-by-which-GLP%E2%80%A6-image-1+%281%29.jpg Gallery A scientific diagram illustrating the weight-independent GLP-1 RA modulation of the HPG axis in PCOS. It includes sections on schematic overview of the hypothalamic-pituitary-gonadal axis, hypothalamic mechanisms, neuroanatomical connectivity, ovarian-level mechanisms, the RASA1/Ras/AKT/GnRH pathway in PCOS, kisspeptin hierarchical signaling, and future clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7f692740-f0f2-4107-90e6-fb230dce67a3/The-preclinical-evidence-for-weight-independent-mechanisms-by-which-GLP%E2%80%A6-image-1.jpg Gallery A detailed diagram showing the mechanisms regulating the hypothalamic-pituitary-gonadal axis in weight-independent GLP-1 RA modulation of HPG axis, including schematic overview of brain, ovaries, and related pathways, with sections on hypothalamic mechanisms, ovarian mechanisms, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/85bb1313-31a0-4aa3-97b7-96edc05c9532/This-news-highlights-a-significant-population-based-study-published-in%E2%80%A6-image-1.jpg Gallery A detailed infographic summarizing a study on maternal endometriosis and the risk of congenital anomalies in Ontario from 2006 to 2021. It includes sections on study design, risk visualization, specific anomalies like cleft palate, hypospadias, and pulmonary artery stenosis, contributing factors such as systemic inflammation, IVF usage, and delayed childbearing, and clinical implications emphasizing prenatal risk assessment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a2199664-06af-4c59-808f-5e1b3ea43e84/This-unprecedented-and-comprehensive-international-health-policy-initia%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Global Renaming and Implementation of PCOS to Polvnedocrine Metabolic Ovarian Syndrome (PMOS): Consensus Process, Rationale, Disease Features, and Transition Strategy' showing sections on global consensus, key features, and transition plan. Sections include diagrams, charts, and icons depicting processes, abnormalities, and strategies for implementation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c5e1e894-0ad6-419e-a16a-5d4305ea714b/What-is-the-impact-of-endometriosis-on-female-fertility-Endometriosis-a%E2%80%A6-image-1.jpg Gallery Diagram titled 'Impact of Endometriosis on Female Fertility' showing how endometriosis affects various aspects of female reproductive health, including anatomical distortion, ovarian function impairment, inflammatory pathways, and endometrial receptivity, with evidence from oocyte donation models. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8c76d7f4-7943-423b-a36c-b6ea8498dcc7/Women-of-reproductive-age%2C-especially-those-with-polycystic-ovarian-syn%E2%80%A6-image-1.jpg Gallery An infographic showing the effects of GLP-1 receptor agonists on ovarian physiology and reproductive outcomes in women with PCOS. The diagram includes sections on clinical overview, ovarian mechanism action, clinical trial outcomes, animal study outcomes, and knowledge gaps. It illustrates how GLP-1 receptor therapy affects menstrual regularity, body weight, hormone levels, and ovarian function, and summarizes benefits and detriments from clinical and animal studies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6f1baa53-6237-4361-b50a-a0962898b3c4/Women%E2%80%99s-health-care-is-notoriously-under-researched-and-underfunded.jpg Gallery Diagram explaining the renaming and reframing of women's health syndrome from PCOS to PMOS. The image includes sections on historical context, why the name change, and patient impact. The historical context notes the term 'Polycystic Ovary Syndrome' was coined in 1935, based on visualized cysts which are actually follicles. The name change to PMOS in 2025 reflects understanding of metabolic and hormonal factors, with a focus on mental health, weight, and skin changes. The patient impact highlights 170 million affected worldwide, with 1 in 10 Canadian women during reproductive years facing issues like irregular periods, infertility, hirsutism, obesity, mental health issues, and skin changes. The diagram emphasizes the slow challenge of changing official terminology and advocates for improved diagnosis, care, and awareness over the next ten years. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/998951dd-9205-4b8f-9433-00c4a9ba0468/For-endometriosis-The-hypothesis-is-complicated-by-local-aromatase-dri%E2%80%A6-image-1.png Gallery Infographic explaining endometriosis and related therapies. Sections show systemic estrogen suppression via GnRH agonist, endometriotic lesion with local estrogen production, clinical consequences like persistent symptoms and therapy options such as aromatase inhibitor therapy and postmenopausal endometriosis. Diagrams include pelvic cross-section, hormone pathways, and affected ovaries. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/952b5cdf-1ff5-4991-a91a-6abd384dde60/Summary-Comparison-Parameter-GnRH-Agonists-GnRH-Antagonist-%2B-Add-Back-G%E2%80%A6-image-1.png Gallery Comparison chart of GnRH Agonists, GnRH Antagonist + Add-Back, and GnRH Antagonist Monotherapy for uterine fibroids, detailing efficacy, safety, onset, duration, side effects, administration, and best use cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/80cd8932-a223-435a-8ca7-9a994474aad0/The-Estrogen-Threshold-Hypothesis-in-Endometriosis-and-Fibroids-Origin%E2%80%A6-image-1.png Gallery Diagram illustrating the estrogen threshold hypothesis, showing tissue sensitivity hierarchy from most sensitive to least sensitive, based on estradiol E2 levels. It displays low, optimal, and high E2 zones with associated effects, and a therapeutic window for serum estradiol levels. The figure includes tissue types such as calcium metabolism, gonadotropin secretion, vaginal growth, lipid metabolism, liver protein production, breast cancer, and endometriosis/fibroids, with their corresponding estradiol concentration ranges. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0dc6bea1-1ef7-4e6d-b182-0edf0d4f9bb9/The-Volume-Reduction-vs+%281%29.png Gallery Diagram showing the relationship between volume reduction and symptom control in estrogen suppression for menopause treatment, including preoperative volume reduction with GnRH agonist and long-term symptom management with GnRH antagonist and add-back therapy. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f6841135-2284-4b0f-8ae5-41400cac98cf/The-Volume-Reduction-vs.png Gallery Chart comparing volume reduction and symptom control in estradiol suppression treatments for ovarian conditions, with sections on preoperative volume reduction, chronic symptom control, clinical goals, required E2 levels, achievable with, key evidence, and treatment objectives. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fb023605-eabb-4a06-8ee7-ad0f17ce4f51/A-2024-review-in-the-NEJM-noted-that-oral-GnRH-antagonist-combinations%E2%80%A6-image-1.png Gallery Diagram of treatment for symptomatic uterine fibroids using oral GnRH antagonists, showing mechanism of action, effects during treatment, limitations, recurrence, and fertility considerations with surgery only for preoperative volume reduction. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a91d4eb1-1b1f-4f4b-b597-e171f6210960/Background-We-aimed-to-evaluate-the-feasibility-and-safety-of-hysteros%E2%80%A6-image-1.png Gallery Flowchart illustrating the safety and feasibility of hysteroscopic myomectomy (HM) in infertile patients with FIGO type 0, I, and II uterine fibroids. It includes steps for patient selection, HM procedure, immediate post-op protocol, follow-up timeline, clinical pathways and outcomes, secondary procedures and outcomes, safety and complication data, and conclusion. The flowchart shows that HM is safe, with 78% conception rate, 42% live birth rate, and 12% developed intrauterine adhesions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d03bb244-b69e-45b8-b03a-cc6ac8c3e515/Diagnostic-Challenges-Symptom-Overlap-Core-symptoms-overlap-substantial%E2%80%A6-image-1.png Gallery Table comparing diagnostic symptom overlap between fibroids and endometriosis, listing features such as pelvic pain, dysmenorrhea, heavy menstrual bleeding, infertility, dyspareunia, and bowel/bladder symptoms, with respective characteristic features and distinguishing clues. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d74d725a-64be-47f0-a11d-cf82e13d57a6/Evidence-Gaps-and-Emerging-Data-The-most-critical-gap-is-the-absence-of%E2%80%A6-image-1.png Gallery A detailed infographic titled 'Management and Knowledge Gaps in Intramural (FIGO Type 3) Uterine Fibroids and IVF Outcomes' divided into five sections explaining fibroid location, evidence gaps, meta-analysis data, management pathway, and key research takeaways, with diagrams, arrows, and text. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/57c9a20c-99a3-4676-af52-cf9c2a34fb5b/export-1780109692427.png Gallery Diagram of a uterus with multiple fibroids and polycystic ovarian morphology, showing the uterus, cervix, vagina, fallopian tubes, and ovaries with measurements and descriptions of fibroids. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/538b1acc-0c5c-4cf5-8a44-9570ecbe0b9f/export-1780109805543.png Gallery A medical illustration of female reproductive anatomy showing the uterus, endometrium, bladder, rectum, ovaries, and fallopian tube. It highlights a retroverted uterus and features a detailed inset of the posterior compartment, depicting fixed uterine retroflexion, ovarian immobility, and ovaries behind the cervix. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/abdb7e8e-9352-46dd-98f5-8da89e531a7b/export-1780109967124.png Gallery Diagram of female reproductive system with labeled parts including ovaries, fallopian tubes, uterus, endometrium, myometrium, cervix, vagina, and bladder. Shows fibroids and other structures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c7ee1cc-e0cf-46e8-a8c0-498bbde81b94/Inflammatory-and-Immune-Mechanisms-Both-conditions-involve-chronic-infl%E2%80%A6-image-1.png Gallery Diagram illustrating shared and distinct inflammatory, immune, and genetic mechanisms in uterine fibroids and endometriosis, showing tissue origins, genetic mutations, immune pathways, and cellular activity alterations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/28a4c175-06ed-4ebc-9c53-1646c8a001de/Medical-Pretreatment-Before-Fertility-Treatment-GnRH-Agonists-The-Only%E2%80%A6-image-1.png Gallery A chart comparing the effects of GnRH agonists on endometriosis and fibroids, showing clinical study data, effectiveness, regrowth, and expert recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/63de4dc7-7a2c-43bc-8c58-81a45803a87c/Mendelian-randomization-meta-analyses-combining-FinnGen-and-UK-Biobank%E2%80%A6-image-1.png Gallery Diagram illustrating the mechanistic and genetic links between endometriosis, uterine fibroids, and uterine leiomyomas. It highlights shared risk factors, the WNT/β-Catenin pathway, and genetic risk loci involving chromosome 1 and the WNT4 gene. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/29617cd3-bf8f-4c85-83b6-83064c03a608/Polyendocrine-metabolic-ovarian-syndrome-%28PMOS%29%2C-which-was-recently-cha%E2%80%A6-image-1.png Gallery Diagram providing an overview of polycystic ovary syndrome (PCOS) and its related diagnostic criteria, comorbidities, and lifestyle impacts. The image includes sections on the definition and history of PMOS, diagnostic criteria involving chronic anovulation, hyperandrogenism, and polycystic ovaries, comorbidities like obesity, metabolic syndrome, and cardiovascular disease, early diagnosis heterogeneity, and lifestyle interventions leading to improved symptoms and outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fc5fe8c0-552e-4a03-9276-b5ec247dcdc5/Polyendocrine-Metabolic-Ovary-Syndrome-%28PMOS%29-is-recognized-as-the-most%E2%80%A6-image-1.png Gallery Overview infographic of diagnosis and management pathways for Polycystic Ovarian Syndrome (PCOS). Sections cover diagnostic criteria, work-up, clinical features, risks, management strategies, and special populations. Visuals include diagrams, icons, and text descriptions of symptoms, tests, and treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3473ee00-2d0a-462a-bd9a-40f709226d21/Practical-recommendation-Surgeons-performing-myomectomy-in-fertility-p%E2%80%A6-image-1.png Gallery Diagram presenting guidelines on ovarian endometriosis treatment, including patient counseling, surgical risks, and prevention strategies. Sections cover endometriosis management options, risks of ovarian reserve loss from excision and myomectomy, and adhesion formation prevention methods. Visuals include diagrams of the female reproductive system and surgical procedures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d9939166-e5a4-40fe-a300-44670d87840c/Progesterone-Signaling-Shared-Pathway%2C-Divergent-Roles-Progesterone-pl%E2%80%A6-image-1.png Gallery Diagram illustrating progesterone signaling pathways: shared pathway in endometriosis and fibroids, highlighting divergent roles. Endometriosis shown with progesterone resistance, and fibroids with progesterone-driven growth, including therapeutic implications of drug progesterone and progestins. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2f53cc43-c1a6-46f7-bce8-8468a40a4c14/Relugolix-combination-40-mg-%2B-E2-1-mg-%2B-NETA-0.png Gallery A detailed infographic explaining relugolix combination therapy for endometriosis and fibroids, including FDA-approved mechanisms, efficacy data, treatment challenges, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1ad5e41e-338a-48ea-8d37-60882db0e9de/Shared-Pathophysiology-Estrogen-Dependence-and-Local-Estrogen-Productio%E2%80%A6-image-1.png Gallery Diagram showing shared pathophysiology of estrogen dependence in endometriosis and uterine fibroids. The left side depicts endometriosis, with illustrations of normal endometrial tissue and ectopic endometriotic lesions, highlighting cellular mechanisms involving androgen and estrogen, aromatase CYP19 enzyme, and estrogen-rich microenvironment. The right side shows uterine fibroids (leiomyomas), with fibroid cells producing aromatase and promoting tumor growth, alongside normal myometrium. Central link indicates estrogen dependency and shared features like aromatase overexpression and local estrogen biosynthesis in both conditions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cf7055bf-08e0-457b-a577-ec76c768b81a/Summary-Uterine-fibroids-and-endometriosis-co-occur-3%E2%80%937-times-more-freq%E2%80%A6-image-1.png Gallery Infographic summarizing the shared pathophysiology, genetic basis, clinical challenges, pharmacological and surgical approaches to uterine fibroids and endometriosis, highlighting genetic links, diagnostic challenges, treatment strategies, and importance of considering endometriosis in certain surgical cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fa447800-3003-4e03-aa43-c816a9429b47/Surgical-Co-Occurrence-Data-Surgical-series-consistently-reveal-unexpec%E2%80%A6-image-1.png Gallery An infographic about the surgical co-occurrence of endometriosis at myomectomy, showing overview of findings, key independent predictors, subgroup modifiers, and a world map with geographic variation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/15cedd37-1ce1-4550-a857-7e670848059a/The-presence-of-uterine-fibroids-impacts-fertility-through-multiple-mec%E2%80%A6-image-1.png Gallery Diagram showing mechanisms by which uterine fibroids impact fertility and management strategies, including uterine anatomy, fertility outcomes, clinical algorithms, assisted reproduction, and obstetric outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6b89d297-139b-4d10-a764-326150420c00/A-multimodal-approach-combining-pharmacologic-and-behavioral-interventi%E2%80%A6-image-1.jpg Gallery Flowchart showing pharmacologic and behavioral interventions for vasomotor symptoms and perimenopause, including medications like HT, SSRIs, Fezolinetant, Gabapentin, and lifestyle tips such as diet, exercise, and supplements. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/97f8490a-3125-4da1-8262-8a8331126fc1/Abstract-Background-Fluoroscopic-hysterosalpingography-%28HSG%29-with-Lipi%E2%80%A6-image-1.png Gallery Infographic about safety and efficacy of outpatient ultrasound-guided lipiodol HSG in unexplained infertility. Includes study workflow, outcomes timeline, complications, and conclusions. Shows 52 participants, safe procedure, no major complications, 57% biochemical and 53% clinical success rates, with thyroid monitoring recommended. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3fd7324b-f99c-45ac-aea2-5bea9a34af4c/Based-on-the-abstract-provided%2C-here-is-a-summary-of-the-key-findings-r%E2%80%A6-image-1.jpg Gallery Diagram comparing healthy endometrium and endometriosis-associated infertility. Left shows healthy tissue with normal epithelial and stromal cells and successful embryo implantation. Right shows endometriosis with altered cell interactions, decreased ESR1 and PGR, impaired embryo implantation, and AI analysis confirming correlation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/13e94d37-71b1-46d1-9d60-55f130c46e90/export-1779537814461.png Gallery A comprehensive infographic discussing HRT and sarcopenia, including clinical evidence, observational evidence, resistance exercise, and biological mechanisms in skeletal muscle. It features graphs, key findings, and scientific data supporting the benefits of HRT and exercise on muscle mass, strength, and gene expression. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/98a9a1b0-066e-4483-a545-3c2c78fe7010/export-1779537821853.png Gallery A detailed infographic comparing hormone replacement therapy (HRT) and sarcopenia, focusing on biological mechanisms and clinical evidence, including meta-analyses, key metrics, and exercise impact on muscle mass and strength in postmenopausal women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c0c46243-9f6b-496d-ac7a-f81ffe55f84b/export-1779537841762.png Gallery Infographic about menopause and sarcopenia, discussing biological mechanisms, clinical consequences, diagnosis, and actions for muscle health during aging. Includes charts, icons, and summary points. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a8c45bd0-0e5d-46a9-acea-2cbcbafda469/export-1779537848784.png Gallery An infographic titled "Menopause & Sarcopenia: The Complex Decline and Accelerated Muscle Loss" explains the biological mechanisms and clinical consequences of muscle loss during menopause. It highlights the decline in muscle density starting at the premenopause stage, with a notable jump during the transition to postmenopause. Key mechanisms include falling estradiol and rising FSH levels leading to metabolic shifts, increased visceral fat, and anabolic resistance. The clinical consequences discussed include osteosarcopenia, metabolic health issues, and reduced brain-muscle link. The infographic also summarizes the reduction in lean mass and muscle strength, and provides diagnostic thresholds and a questionnaire for sarcopenia detection. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/365a51ac-1a81-4c95-99ab-7757b252e0aa/export-1779537862624.png Gallery Infographic titled 'Testosterone Therapy for Postmenopausal Women: Clinical Summary' with sections on physiology, efficacy, what testosterone does not improve, prescribing recommendations, warnings, safety, contraindications, and key takeaways. Graphics include charts, icons, and checklists. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a4259767-45f3-4b26-a687-1001d71861d8/export-1779537870258.png Gallery Infographic about testosterone therapy for postmenopausal women, highlighting the evidence-based indication for hyposexual sexual desire disorder, safety profile, prescribing recommendations, and contraindications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7e36c9b5-9373-4129-9a4a-9e9e2d27ad2e/export-1779541972246.png Gallery An infographic titled 'The Yearning for Movement Framework' explains the process of managing endometriosis-related chronic pain through movement. It includes four phases: The Yearning, Monitoring & Assessing, Adapting & Taking Action, and Healthcare Support Gap. The illustration shows a woman contemplating her desire to move, a filter for pain levels, energy, and social costs, and pathways for action. Additional sections highlight the cycle of desire to move, clinical implications like validation and tailored support, and the pillars of support and individual well-being. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/57e6dd6a-d555-48a9-90d7-4c3ec358391b/export-1779543260663.png Gallery A comparative diagram showing the dysregulation of ESR1 and PGR in endometriosis-associated infertility versus healthy receptive endometrium. It highlights differences in epithelial and stromal layers, receptor expression levels, and molecular signatures, illustrating implantation success in healthy endometrium and failure in endometriosis with signs of epithelial overexpression, aberrant receptor levels, and reduced ESR1. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/96bbeb0c-236d-4891-b9d8-7f55ef0a5e7b/export-1779543272052.png Gallery Diagram illustrating the effects of dysregulation of ESR1 and PGR in endometriosis-associated infertility. It compares healthy receptive endometrium with endometriosis-associated infertility, showing hormonal regulation, cellular changes, molecular signatures, and clinical implications, including decreased ESR1 and PGR levels and their impact on endometrial receptivity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3e2d4f0f-c479-45ab-8609-edcbfec70138/export-1779588830799.png Gallery An infographic illustrating menopause transition, hormone optimization, and their effects on health and longevity. The left side shows declining estrogen, increased cardiovascular risk, metabolic dysregulation, bone density loss, and cognitive and mood changes. The right side highlights hormone support with estradiol, progesterone, and testosterone to optimize energy, balance, strength, and vitality. The background features a sunset landscape with mountains and a woman silhouette transitioning from disintegration to vitality. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/21921434-2764-4a6e-8557-fd1652704b4f/export-1779588836744.png Gallery An infographic illustrating menopause transition and hormone optimization for female longevity. It shows the decline of estrogen and associated health risks such as cardiovascular risk, metabolic dysregulation, bone density loss, and mood changes. On the right, there are molecular structures of estrogen, progesterone, and testosterone with their benefits. The bottom emphasizes optimizing cardiovascular resilience, metabolic balance, skeletal strength, and cognitive vitality to turn menopause from decline into longevity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5daf7ffc-82c0-4cb9-be6c-6d3b6b98d0ac/export-1779589671341.png Gallery Infographic explaining menopause transition as a systemic metabolic shift, highlighting neurological, cardiovascular, and metabolic health, and emphasizing the importance of early intervention and lifestyle changes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fccb86f0-f0ac-4b32-863e-2ab74387bb40/export-1779589677933.png Gallery An infographic titled 'The Menopausal Transition: A Systemic Metabolic Shift' explaining the effects of ovarian function cessation on body systems. It features three pillars: Neurological, Cardiovascular, and Metabolic, detailing health changes during menopause. The neurological pillar lists brain health changes, cognitive aging, mood regulation issues, and sleep disturbances. The cardiovascular pillar mentions heart health shifts, vascular decline, increased risk, and lipid changes. The metabolic pillar notes energy use, metabolic rate, weight gain, and insulin sensitivity alterations. The diagram highlights the 'Critical Juncture' as a key window for intervention to prevent health decline. It recommends clinical hormone therapy and lifestyle changes to support long-term health. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5f6942d2-c51b-47f0-8bf2-b08d26cbd2ac/export-1779590007601.png Gallery An infographic titled 'The Blueprint for Women's Longevity' illustrating a life-course approach to women's health, from early drivers of long-term health to later years, emphasizing prevention, health management, and specialized focus areas, with sections on foundational health, reproductive years, early adulthood, midlife, postmenopause, and later years, including key health pillars like medical management, physical function, nutrition, mental well-being, and lifelong partnership. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a643db88-165f-4959-9c4a-5052a0a4c882/export-1779590016045.png Gallery Infographic titled 'The Blueprint for Women's Longevity: A Proactive Life-Course Approach to Women's Health'. It shows a timeline from 20s to 80s+ highlighting early conditions like PCOS and Endometriosis affecting gynecological health earlier, and the 'vital window' around age 40 for estrogen decline, bone health, cardiovascular and cognitive health. The infographic emphasizes a shift from reactive to proactive care through preventive strategies, early intervention, multidisciplinary support, and the role of gynecologists and longevity physicians in chronic disease prevention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c2a6ac9c-68cc-4b88-99df-c5dee8aa2776/export-1780024121205.png Gallery Diagram showing the relationship between PCOS, hormonal features, and breast cancer risk. It illustrates the hormonal regulation involving hypothalamus and pituitary, and their effects on estrogen, androgens, and PCOS ovaries. The diagram highlights factors influencing tissue in breast tissue, such as estrogen exposure, cell proliferation, inflammation, and epigenetic changes. It mentions that evidence on the link between PCOS and breast cancer risk is inconclusive, with some factors like hormonal disturbances and metabolic health playing a role. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f1a791e3-b4c9-47b2-a687-8ce5a0aacef6/export-1780024127792.png Gallery Diagram illustrating hormonal modulation and epidemiological trends in PCOS and breast cancer risk. Shows hormonal regulation background, mediating metabolic pathways like insulin resistance, obesity, type 2 diabetes, and inflammation, affecting breast tissue through altered hormone signals, endocrine, and metabolic environment, influencing breast growth, development, and cancer risk. Includes studies, conflicting data, and research methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cd91fe7b-4523-4be4-82e4-5fd8a9a56c81/export-1780025529619.png Gallery Infographic about ovarian cysts in polycystic ovary syndrome (PCOS), showing differences between PCOS 'polycystic' appearance and pathogenic cysts, ultrasound images, and statistics on features and risk factors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0b59c133-5bae-480f-b332-4c3fc6218a9e/export-1780025536102.png Gallery Chart comparing ovarian morphology in PCOS and normal ovaries, with ultrasound images and statistics on ovarian features and prevalence. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2fff1dc7-6348-470c-b685-91ba4492653e/Maintaining-hormonal-equilibrium-is-a-key-determinant-of-women%27s-health%E2%80%A6-image-1.png Gallery Diagram illustrating transdermal hormone therapy in menopausal and postmenopausal women's health, including hormonal changes during menopause, therapeutic modalities (oral vs. transdermal), and modern clinical integration for improved health outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e00675e8-cf14-4979-87d8-8f7042da9245/Objective-Across-the-lifespan%2C-more-women-than-men-report-abdominal-bl%E2%80%A6-image-1.png Gallery A scientific infographic showing factors affecting abdominal bloating severity during menopause transition. It depicts a study with 291 women across different stages, urine sample collection, and modeling of age and reproductive aging. Key findings include that tension, anxiety, age, and testosterone levels influence bloating severity, with tension and anxiety increasing severity, while age and testosterone levels have protective effects. The infographic includes a legend indicating severity and menopause stages. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6d1d042b-02f1-4c58-89ee-ff4c8ed906f5/Perimenopause-and-job-Analyzed-query%2C-searched-for-evidence-Perimenopau%E2%80%A6-image-1+%281%29.jpg Gallery An infographic titled 'Evidence-Based Workplace Interventions to Support Work Ability and Cognitive Function During Perimenopause'. It includes statistics about perimenopausal symptoms, work impact, and recommendations. The infographic is divided into sections on symptoms, work impact, workplace recommendations, and interventions including therapy, exercise, mind-body practices, menopause clinics, medication, and integrative approaches. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c04ad66-9c2c-476f-8304-6e57ff827143/Perimenopause-and-job-Analyzed-query%2C-searched-for-evidence-Perimenopau%E2%80%A6-image-1.jpg Gallery Infographic titled "Perimenopause, Symptoms, and Impact on Work Performance" divided into sections: 1) Prevalence and Symptom Burden showing 80% of perimenopausal workers experience symptoms like fatigue (54%), sleep difficulty (47%), poor concentration (44%), and poor memory (40%), with 27.5% experiencing frequent symptoms. 2) Work Outcomes illustrating lower at-work productivity due to menopause symptoms such as presenteeism (12-17%), absenteeism (9-13%), and increased sick leave (18%). 3) Workplace Recommendations including flexible scheduling, ability to take breaks, manager education, environmental modifications, and healthcare coverage. 4) Evidence-Based Interventions and Clinical Management with workplace interventions like CBT, exercise, yoga, clinic consultation, and symptom management options including hormone therapy, non-hormonal options, and integrative approaches. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4c8afb87-cf32-4eaa-838b-4e7563dfaa58/Perimenopause-and-job-Analyzed-query%2C-searched-for-evidence-Perimenopau%E2%80%A6-image-1.png Gallery An infographic titled 'Evidence-Based Workplace Interventions to Support Work Ability and Cognitive Function During Perimenopause' showing statistics, symptoms, and recommendations. Key points include 80% of perimenopausal workers experience symptoms, with a 65% reduction in work performance, costing $1.8 billion annually in the US. Common symptoms listed are fatigue (54%), difficulty sleeping (47%), poor concentration (44%), poor memory (40%), mood/psychological issues, and hot flashes/night sweats. Impact on work outcomes includes presenteeism, absenteeism, reduced career development, and high job demands. Workplace recommendations include flexible scheduling, manager education, environmental modifications, and healthcare plan review. Evidence-based interventions are categorized into cognitive-behavioral therapy, exercise, mind-body approaches, menopause clinic consultations, diet and health education, hormone therapy, non-hormonal medications, and integrative approaches. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a6c13d09-9f4e-4c08-9861-b48ab229416a/Perimenopause-significantly-impacts-work-performance%2C-productivity%2C-and%E2%80%A6-image-1.jpg Gallery Infographic titled 'Perimenopause Impacts Work.' It includes illustrations of women and data points about menopause symptoms, work performance, and career impact; a pie chart showing 80% experience symptoms, bar and percentage data on work impairment, a calendar illustration about sick leave, and icons representing job demands and stress. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/745c753b-e7b2-4888-8ed4-cd43cd652f5c/Perimenopause-significantly-impacts-work-performance%2C-productivity%2C-and%E2%80%A6-image-1.png Gallery An infographic about perimenopause impacts at work displaying five sections: 1) Perimenopause impacts work with illustrations of women and charts; 2) Symptom prevalence at work shown as a pie chart indicating 80% experience symptoms and common symptoms like fatigue, difficulty sleeping, poor concentration, and poor memory; 3) Cognitive impacts highlighting differences between premenopausal and perimenopausal women with icons for attention and memory; 4) Work outcomes with data on presenteeism, absenteeism, career impact, and high job demands, including charts and icons; 5) Key findings summary emphasizing symptoms, cognitive impacts, absenteeism, and career effects. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0c7beb97-9111-422b-a86a-213fd430bc1b/The-most-common-workplace-challenges-during-perimenopause-are-neurocogn%E2%80%A6-image-1.jpg Gallery An infographic illustrating the impact of perimenopause symptoms in the workplace, including prevalence among healthcare workers, specific symptoms like fatigue, sleep difficulty, poor concentration, brain fog, and their effects, along with symptoms specific to work, career consequences, environmental factors, workplace support recommendations, and the support gap. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dcdb4daa-6da4-4ccc-9ec0-7fa16fa2cb7a/The-most-common-workplace-challenges-during-perimenopause-are-neurocogn%E2%80%A6-image-1.png Gallery An infographic titled 'Impact of Perimenopause Symptoms in the Workplace' with three sections. The first section shows symptom prevalence among healthcare workers, highlighting fatigue (54%), difficulty sleeping (47%), poor concentration (44%), poor memory (40%), and brain fog (~70%). The second section describes symptom-specific and broader work effects, including cognitive fog, vasomotor symptoms, and psychological changes, and their career consequences like presenteeism, absenteeism, and job exit. The third section illustrates workplace environmental factors causing support gaps, such as insufficient restrooms and long hours, and offers recommendations like open culture, flexible scheduling, temperature control, and manager training, noting only 2-6% of workplaces provide adequate menopause support. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8d088283-cb79-48b9-8220-ce9b06d6f4ed/The-relationship-between-PCOS-and-breast-cancer-risk-has-been-histori%E2%80%A6-image-1.png Gallery Illustration showing the evolution of evidence linking PCOS and breast cancer risk. Sections include: no association with historical studies; modest risk detection in emerging evidence; reasons for discrepancies such as short follow-up and small cohorts; biological pathways in postmenopausal PCOS including hormone and receptor changes, inflammation, and obesity; and guideline positions emphasizing no screening change. https://www.endosure.info/new-page-1 daily 0.75 2026-05-23 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5da8c15e-9dac-4a9c-88c7-fe0e76054dd3/Women%E2%80%99s-health-care-is-notoriously-under-researched-and-underfunded.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e0f81961-89c2-4337-9a47-79d5226b714c/Gemini_Generated_Image_zh9ynyzh9ynyzh9y.png